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Acute kidney injury (AKI) shows a rising incidence especially in the elderly above the 
age of 65. AKI does not only lead to an acute impairment of renal function but also 
comes with a strongly increased risk of adverse outcome including mortality. Since 
there are no therapies for AKI prevention measures this would be of utmost 
importance. However, clinically established specific interventions protecting the 
kidney are not available. Prevention of kidney damage can be addressed by the 
concept of preconditioning which exploits the fact that damaging stimuli at a sublethal 
dose can activate cellular protection programs that increase resistance to future 
stressors. One of these preconditioning protocols is based on the activation of the 
hypoxia signaling pathway which has been shown to prevent AKI in animal models. 
However, the underlying mechanisms are still unknown hampering translation to the 
clinical setting. A recent study highlighted the importance of RNA binding proteins 
(RBPs) and hinted towards differences in RNA-protein binding upon exposure to 
hypoxia. In the last decade, the list of known and putative RBPs has been increasing 
in size and complexity across species. Thanks to the development of techniques that 
allow crosslinking of RNA to interacting proteins followed by both RNA pulldown and 
mass spectrometry (RNA interactome capture). However, little is still known about the 
molecular function of many RBPs and their global dynamics in different conditions. In 
this study, we chose C. elegans as a model organism to further dissect the complex 
biological question of (1) how hypoxia-inducible factor signaling modulates the RNA 
protein interactome and (2) how these RBPs may impact on stress resistance. 
Performing RNA interactome capture in wild-type and vhl-1 mutant worms we 
identified 1354 RBPs 270 out of which had not been described before. Among these, 
we found 30 RBPs to be overrepresented in vhl-1 mutant and 50 RBPs in wild-type 
worms. A comparison of the proteome in both strains showed that all but one of these 
are not differentially regulated on the level of protein abundance pointing towards 
differences in RNA-binding capacity. Lifespan extension in the nematode reflects 
increased stress resistance. To enable screening of this phenotype after knockdown 
of RBP candidates in C. elegans, we established the automated lifespan machine. 
Using this approach, we could show longevity induced by knockdown several of 
these RBPs. Our results will significantly add to the understanding of the RBPome in 




Die Inzidenz für eine akute Nierenschädigung (AKI) steigt insbesondere bei älteren 
Menschen über 65 Jahren. AKI führt nicht nur zu einer akuten Beeinträchtigung der 
Nierenfunktion, sondern birgt auch ein stark erhöhtes Risiko für Mortalität. Da es 
keine Therapien für AKI gibt, wären Präventionsmaßnahmen von größter Bedeutung. 
Die Prävention von Organschäden wird durch das Konzept der Präkonditionierung 
angegangen, bei dem die Tatsache ausgenutzt wird, dass schädliche Reize bei einer 
subletalen Dosis zelluläre Schutzprogramme aktivieren können, die dann die 
Resistenz gegen zukünftige Stressfaktoren erhöhen. Einer dieser Präkonditionierung 
Protokolle beruht auf die Aktivierung des Hypoxie-Signalwegs. Die zugrunde 
liegenden Mechanismen sind jedoch noch unbekannt, was eine Translation in die 
Klinik bislang verhindert hat. Eine Studie aus unserer Gruppe unter Verwendung von 
Zellkulturen deutet auf Unterschiede in der Bindung von RNA-Bindungsproteinen 
(RBPs) an mRNA während Hypoxie hin. In den letzten zehn Jahren hat die Liste der 
bekannten und mutmaßlichen RBPs an Größe und Komplexität zugenommen. Das 
gelang durch die Entwicklung von Techniken, die die Vernetzung von RNA mit RBPs 
ermöglichen, gefolgt von RNA-Pulldown und Massenspektrometrie (RNA-Interaktom-
Capture). In dieser Studie haben wir C. elegans als Modellorganismus ausgewählt, 
um die komplexe biologische Frage weiter zu untersuchen: (1) wie durch Hypoxie 
induzierbare Faktorsignale das RNA-Protein-Interaktom moduliert wird und (2) wie 
diese RBPs die Stressresistenz beeinflussen können. Bei der Durchführung des 
RNA-Interaktom-Captures in Wildtyp und vhl-1 Mutanten Würmern identifizierten wir 
1354 RBPs von denen 270 zuvor noch nicht beschrieben worden waren. Zusätzlich 
fanden wir 30 RBPs, die in der vhl-1 Mutante und 50 RBPs in Wildtypischen 
Würmern überrepräsentiert waren. Ein Vergleich des Proteoms in beiden Stämmen 
zeigte, dass alle bis auf ein RBP nicht unterschiedlich auf der Ebene der 
Proteinhäufigkeit reguliert sind, was auf Unterschiede in der RNA-Bindungskapazität 
hinweist. Um ein Screening der Lebensspanne nach dem Herunterregulieren von 
RBP-Kandidaten in C. elegans zu ermöglichen, haben wir die automatisierte 
Lebensdauer-Maschine etabliert. Mit diesem Ansatz konnten wir eine Langlebigkeit 
nachweisen, die durch das Herunterregulieren mehrerer dieser RBPs verursacht 
wurde. Unsere Ergebnisse werden das Verständnis des RBPome im Nematoden und 






3.1 The kidney and its function 
Human kidneys are a pair of organs located beneath the rib cage in the posterior 
abdomen. They have the size of a fist and weigh on average 135 g - 162 g (Rao and 
Wagner 1972). Every kidney contains about one million nephrons (Puelles et al. 
2011). The nephrons are located in the renal cortex and renal medulla (Figure 1). 
Each nephron is divided into the renal glomerulum and the renal tubule. The renal 
tubule consists of the proximal convoluted tubule, the loop of Henle, the distal 
convoluted tubule and the collecting duct (Figure 1) (Wallace 1998).  
 
Figure 1: The anatomy of a human kidney.  
Cross-section of a human kidney (left) cortex and medulla is indicated. The black box marks the region 
which is viewed in detail (right). On the right side, a nephron is depicted with all parts needed for 
filtration, reabsorption and secretion involving the glomerulus, the proximal convoluted tubule, loop of 
Henle (descending and ascending limb), distal convoluted tubule and collecting duct. 
Filtration of the blood takes place in the glomerulum. Water and solutes are filtered in 
a size and charge-dependent fashion and collected in the Bowmans capsule, while 
proteins above approximately 50 kD are retained in the blood. Along the renal tubule 





sections in various amounts takes place. The kidneys filter about 180 liters of fluid 
(primary urine) per day resulting in about 1.5 liter urine output after reabsorption. 
Besides the important filtration function, the kidney participates in hormone secretion, 
blood pressure regulation and bone physiology (Coffman 2014). As a consequence, 
end-stage renal disease is only compatible with life due to the availability of renal 
replacement therapies like dialysis or kidney transplantation. However, even a mild 
loss of kidney function leads to significantly increased cardiovascular morbidity and a 
decrease in life expectancy. 
3.2 Acute kidney injury 
Acute kidney injury (AKI) causes an acute loss of renal function. With increased age, 
there is a higher risk to develop AKI (Xue et al. 2006). Since we live in a society with 
demographic changes that lead to our population getting older and older the 
incidence of AKI is rising. Further, AKI is a major independent risk factor for 
cardiovascular morbidity and mortality (Go et al. 2004). The etiology of AKI can be 
divided into prerenal, intrarenal and postrenal AKI (Farrar 2018). Prerenal AKI is 
caused by decreased renal perfusion or blood flow and is – due to its functional 
nature and as long as intrarenal damage has not occurred yet – usually rapidly 
reversible upon improving perfusion. Intrarenal AKI refers to actual damage to renal 
cells as a consequence of prolonged ischemia or toxic injury. Postrenal AKI is defined 
as an acute obstruction to urinary flow. In the following, I will primarily focus on actual 
intrarenal AKI which – in the majority of cases – is caused by tubular damage and 
acute tubular necrosis. According to “Kidney disease: Improving global outcomes” 
(KDIGO), AKI is defined by the following criteria. Firstly, an increase in serum 
creatinine by 0.3 mg/dL or more within 48 hours. Secondly, an increase in serum 
creatinine to 1.5 times or more to baseline, within the prior seven days. Thirdly, if 
urine volume is less than 0.5 mL/kg/h for at least 6 hours (“KDIGO for AKI” 2012). 
AKI is associated with adverse outcomes including the need for renal-replacement 
therapy, prolonged treatment in the intensive care unit and increased cardiovascular 
morbidity and mortality (P. K. Moore et al. 2018). Consequently, prevention and 
treatment of AKI would be highly beneficial. Unfortunately, there are no therapeutic 
strategies and targeted preventive options have not been established in the clinical 
setting. One problem is the fact, that AKI does not hurt making early detection per se 





increased mortality and morbidity directly due to AKI, acute renal damage also 
increases the risk of chronic kidney disease (CKD) (Chawla and Kimmel 2012). CKD 
is known to be a major independent risk factor of cardiovascular mortality. 
Furthermore, patients with CKD are at increased risk of AKI leading to the situation of 
a vicious circle (Figure 2). This is – at least partly - due to a decrease in cellular 
stress resistance which is particularly important in elderly individuals. It would thus be 
crucial to find ways to activate the body’s own protection and stress resistance 
mechanisms to prevent damage. Such an enhancement of intrinsic stress resistance 
mechanisms is the aim of preconditioning algorithms. 
 
Figure 2: Acute kidney injury - the vicious circle. 
Acute injury leads to a loss of functional kidney tissue reducing the nephron number. As a 
consequence chronic kidney disease develops going along with a reduced tolerance to future 
stressors. This makes the elderly patient more prone to further episodes of acute kidney injury causing 
a vicious circle. Considering the lack of therapeutic options, preconditioning protocols are a promising 
strategy to increase stress resistance and prevent AKI. 
3.3 Preconditioning 
Preconditioning strategies are based on the concept of hormesis. Exposing cells, 
tissues or organisms to a sublethal dose of a stressor induces programs capable of 
preparing the cell to counteracting greater stress stimuli in the future. Importantly, 
these mechanisms are conserved in evolution and lead – activated either by 
environmental stimuli or genetic intervention – to lifespan extension in organisms as 
diverse as worms to humans (Costa et al. 2019; Hwangbo et al. 2020). It has been 
shown that different regimens of dietary restriction can extend the lifespan of 
numerous organisms including yeast, flies, worms, fish and rodents (Fontana et al. 





organs such as heart, brain and kidney upon ischemia-reperfusion (Chandrasekar et 
al. 2001; J. R. Mitchell et al. 2010; Yu and Mattson 1999). Similar to dietary 
restriction, several publications could demonstrate that hypoxia signaling can extend 
the lifespan of flies and worms (Mehta et al. 2009; Müller et al. 2009; Vigne and 
Frelin 2007). Hypoxia describes the state of insufficient or low oxygen supply in 
organs or tissues that leads to the activation of the hypoxia signaling pathway. This 
signaling pathway can also be activated by drugs, ischemic reperfusion or gas 
(Eltzschig and Eckle 2011; Li et al. 2012; Pocock and Nicholls 1998; Provenzano et 
al. 2016). Induction of the hypoxia signaling pathway by prolyl 4-hydroxylases (PHDs) 
inhibitors was able to ameliorate post-ischemic renal injury (X.-L. Zhang et al. 2011). 
Another preconditioning algorithm linked to hypoxia is ischemic preconditioning (IPC). 
IPC has been shown to protect against ischemia-reperfusion injury (Endre 2011; Joo 
et al. 2006). Taken together, the hypoxia signaling pathway is a promising target for 
strategies preventing AKI. 
3.4 Hypoxia signaling 
The hypoxia signaling pathway is predominantly controlled by a group of transcription 
factors termed hypoxia-inducible factors (HIF). HIF proteins are heterodimers and 
consist of an unstable alpha (α) subunit and a stable beta (β) subunit (Kaelin and 
Ratcliffe 2008). There are three HIFα proteins (HIF-1, HIF-2, HIF-3) encoded in the 
human genome. During normoxia, the HIFα subunit is hydroxylated by PHDs on two 
proline residues (HIF-1α: Pro402 and 564; HIF-2α: Pro405 and Pro531) (Strowitzki et 
al. 2019). Hydroxylated HIFα is then recognized and bound by the tumour suppressor 
pVHL (von Hippel-Lindau protein). pVHL is the substrate recognition subunit of an E3 
ubiquitin ligase that mediates HIFα polyubiquitination and subsequent proteasomal 
degradation (Kaelin 2005). The enzymatic activity of PHDs is dependent on the 
presence of oxygen (Epstein et al. 2001). Upon hypoxia, HIFα is no longer 
hydroxylated and bound by pVHL. HIFα gets stabilized and translocates into the 
nucleus where it dimerizes with HIFβ. The HIF heterodimer binds to the hypoxia 
response elements (HRE) and activates the transcription of target genes involved in 
angiogenesis, cell proliferation and survival (Figure 3) (Harris 2002; Kaelin and 






Figure 3: Hypoxia signaling pathway. 
In the presence of oxygen (O2) pVHL binds to HIFα and mediates its ubiquitination followed by its 
proteasomal degradation (left panel). Loss of VHL leads to a stabilization of HIFα (middle panel). 
Similarly, during hypoxia, pVHL is unable to bind HIFα. HIFα gets stabilized, translocates into the 
nucleus and dimerizes with HIFβ leading to the activation of their target genes (right panel).  
Besides the regulation of HIF on the protein level, HIF mRNA can also be regulated 
suggesting a role for RBPs. In human cells treated with CoCl2 (hypoxia mimetic) 
HIF1α protein was further increased upon knockdown of the RBP RBM38 and 
decreased upon overexpression. RBM38 can bind to HIF1α 5′ and 3′UTRs and 
thereby regulate HIF1α mRNA translation (Cho et al. 2015). Another RBP known to 
bind HIF1α mRNA is polypyrimidine tract-binding protein (PTB). PTB primarily binds 
to the HIF1α 3′UTR leading to an increase in HIF-1α translation after hypoxia 
(Galbán et al. 2008). HIF1α mRNA regulation by PTB depends on another RBP, 
human antigen R (HuR). There is evidence that both PTB and HuR need to bind to 
HIF1α mRNA to promote its translation (Masuda et al. 2009). HuR is a well-known 
RBP with many RNA targets besides HIF1α, known for the induction of renal fibrosis 
and inflammation (Brennan and Steitz 2001; Feigerlová and Battaglia-Hsu 2017; 





direct impact on hypoxia signaling. On the other hand, it would be extremely 
interesting to determine how hypoxia signaling changes the RBP landscape. 
3.5 RNA binding proteins 
RNA binding proteins play an important role in cellular biology and explicitly in the 
posttranslational regulation of gene expression. Gene expression starts with the 
transcription of DNA to synthesize RNA molecules and ends with the translation of 
RNA molecules into protein followed by protein turnover. The central steps for 
transcription and translation are initiation, elongation, and termination (Cramer 2019; 
M. J. Moore 2005; Orphanides and Reinberg 2002). Every step of gene expression is 
tightly controlled and regulated (Figure 4). 
 
Figure 4: RBPs involved in post-transcription. 
DNA is transcribed resulting in pre-mRNA for protein coding genes. These pre-mRNAs contain exons 
and introns. Splicing of the pre-mRNA results in the actual mRNA. The mRNA is exported out of the 
nucleus into the cytoplasm. There it can be transported, stored, translated or degraded. RBPs are 
involved in each post-transcriptional regulation step and determine the fate of the RNA. 
RBPs bind RNA throughout all the steps of its production and maturation in the 
different cellular compartments; they regulate RNA translation, modification, 
localization, processing and stability which makes them key regulators of numerous 
cellular functions (Figure 4) (Halbeisen et al. 2008; Hasan et al. 2014; S. R. Lee and 





RNA binding domains (RBD). Among the classical RBDs are the RNA recognition 
motif (RRM), the DEAD motif, the Pumilio/FBF (PUF) domain and the zinc finger 
domains (Cléry et al. 2008; Hall 2005; Rocak and Linder 2004; Zamore et al. 1997). 
With the help of computational biology, RBPs are identified by sequence analysis 
based on these RBDs leading to an increase in the number of RBPs (Kazan et al. 
2010; Tamburino et al. 2013). In addition, the number of RBPs without a classical 
RBD (termed “enigmRBPs”) is rising (Beckmann et al. 2015). The continued increase 
in the number of RBPs, especially enigmRBPs, is due to the recent development of 
improved methods for studying RNA-protein interactions. 
3.6 Methods for the identification of RBPs 
In the last century, the development of high-throughput approaches has given the 
field of RBPs and their identification a boost, so that many new methods have 
emerged. In the past, these methods used either immobilized RNA probes or arrayed 
proteins (Butter et al. 2009; Scherrer et al. 2010). More recently RNA Interactome 
Capture (RIC) was developed to identify RBPs in a systematic, unbiased approach 
(Baltz et al. 2012; Castello et al. 2012). RIC is based on covalently linking RNA with 
RBPs by crosslinking using UV light. For RIC, the standard approach to crosslink 
RNA with RBPs is the usage of UV-C wavelength (254 nm). UV-C leads to the 
formation of covalent links between adjacent bases RNA and amino acids such as 
Phe, Trp, Tyr, Cys and Lys. In contrast, the use of the photoactivatable 
ribonucleosides 4-thiouridine (4SU) or 6-thio-guanosine (6SG) enables crosslinking 
with UV-A (Castello et al. 2012) and allows for pulse-chase experiments. 
Independent from the actual strategy used for crosslinking, polyadenylated RNA is 
captured using oligo(dT) beads. Co-precipitated proteins are released from the beads 
followed by RNase treatment and identification / quantification of the proteins by 
mass spectrometry (Baltz et al. 2012; Castello et al. 2012). By now, RIC has been 
applied to a growing number of samples derived from various organisms, e.g. yeast, 
worms, plants, mouse and humans. Due to technical challenges most experiments 
were performed using cultured cells rather than tissue or whole organisms (Hentze et 
al. 2018). Interestingly, the broad usage of RIC revealed that there are many RBPs 
(enigmRBPs) that lack a classical RNA binding motif and have no known relation to 
RNA biology (Beckmann et al. 2015; Hentze et al. 2018). These enigmRBPs are 





response, spindle organization and protein metabolism (Hentze et al. 2018). Although 
RIC allows the identification of the mRNA bound RBPs it will fail to provide a 
comprehensive identification of proteins interacting with non-polyadenylated RNA. 
Thus, different methods were developed for the identification of RBPs bound to all 
RNA species. Just recently, at about the same time, three methods were published 
based on organic extraction protocols instead of polyA pulldown, called Phenol Toluol 
extraction (PTex), protein-crosslinked RNA extraction (XRNAX) and orthogonal 
organic phase separation (OOPS) (Queiroz et al. 2019; Trendel et al. 2019; Urdaneta 
et al. 2019). These methods – since they are rather based on physical properties of 
RNA-protein complexes than sequence-recognition - do now allow for a 
comprehensive identification of proteins interacting with all kinds of RNA molecules. 
The principle of these methods is based on the purification of RBPs using acidic 
phenol phase separation. Protein–RNA adducts will be separated from free protein 
and RNA. However, noticeable differences between these methods downstream of 
the RBP extraction makes it difficult to compare their data (Smith et al. 2020). Taken 
together, the increasing number of RBPs identified in the last decade is based on 
highly improved methodologies paired with sensitive protein identification by MS and 
the fact that these methods have been applied to a growing number of cell types and 
species. 
3.7 RBP target identification 
The first approaches to identify RNA targets of RBPs emerged in 1979. Lerner and 
Steitz demonstrated that using antibodies against the spliceosomal Sm proteins 
allows the precipitation of small nuclear RNA molecules (Lerner and Steitz 1979). 
This method was the basis to further development and is now known as RNP 
immunoprecipitation (RIP) assay (Niranjanakumari et al. 2002). RIP typically uses 
formaldehyde which crosslinks - besides RNA-protein complexes - also protein-
protein interactions. Using conditions in the RIP assay preserving RNP, it is well 
applicable to identify RNA targets of an entire RNP but is unsuitable to study direct 
RNA-protein interaction. To overcome this issue, crosslinking and 
immunoprecipitation (CLIP) were developed that identify RNA targets of a specific 
RBP (Ule et al. 2003). To date, there are more than 15 different versions of the 
protocol published to improve the efficiency of the protocol steps (F. C. Y. Lee and 





introduced high-throughput sequencing (Licatalosi et al. 2008; Yeo et al. 2009). 
Furthermore, both PAR-CLIP and iCLIP resolve the position of the crosslinked sites 
at nucleotide resolution (Hafner et al. 2010; König et al. 2010). Moreover, in one of 
the most recent improvements of the protocol, enhanced CLIP (eCLIP), the 
amplification of the library could be decreased resulting in an increase in usable read 
fraction (Van Nostrand et al. 2016). However, the basis of all approaches remains the 
combination of an efficient crosslinking technology with protein immunoprecipitation. 
High-throughput sequencing is then used to identify the actual RNA targets. Since 
immunoprecipitation of RBPs is required the model organism has to be chosen 
according to antibody availability or availability of techniques that facilitate genetic 
modification to tag specific RBPs. 
3.8 C. elegans as a model organism 
In the beginning, C. elegans was used in the laboratory of Sydney Brenner to study 
development and the nervous system (Brenner 1974; White et al. 1986). The worm's 
relatively simple nervous system with 302 neurons compared to over 100 billion in 
humans, despite the small number, represents most of the nerve cells identified in 
other organisms. Also, the cuticle is transparent, which makes it possible to observe 
the cells in the living worm (White et al. 1986). C. elegans quickly became a well-
established model organism due to many features such as easy cultivation on agar-
plates, feeding on bacteria and its short lifecycle (Figure 5) (Edgar and Wood 1977). 
The lifecycle of the worms starts with a fertilized egg. After hatching the worm passes 
four larval stages (L1-L4) through molting until it reaches adulthood. A key feature of 
C. elegans is their eutely, the defined somatic cell numbers for hermaphrodites are 
959 cells and for males 1031 cells (Sulston et al. 1980; Sulston and Horvitz 1977). 
These first discoveries were the basis for insight into the genetic regulation of organ 
development and programmed cell death. For these discoveries, the Nobel Prize in 
Physiology or Medicine was awarded to Sydney Brenner, H. Robert Horvitz and John 
E. Sulston in 2002. Another major discovery using C. elegans was RNA interference. 
Thanks to the development of RNAi every gene in the worm can be knocked down 
using simple techniques (Fire et al. 1998). The easy application of RNAi by feeding 
the worms with bacteria expressing RNAi or by soaking them in double-stranded 






Figure 5: The advantages of C. elegans. 
C. elegans quickly developed into an established model organism due to many advantages 
summarized here. They are genetically amenable, many genes and pathways are conserved up to 
human and commercial available RNAi libraries cover most of the genome (black strand mRNA and 
red strand RNAi). Also C. elegans is transparent. Image taken by using Nomarski microscopy with a 
magnification of 5x. Scale bar represents 200 µm. The worms are very cost effective because they are 
simple to maintain. Lifespan experiments can be done easily. They are very suitable for experiments 
where many animals are needed because they have large isogenic progeny. 
 
RNAi uses dsRNA which is processed into single-stranded RNAs (ssRNAs). First, the 
dsRNA is processed into ssRNA by an endoribonuclease called Dicer. Then the 
ssRNA gets in complex with TSN-1 and VIG-1 and together they build the RNA-
induced silencing complex (RISC). The ssRNA directs the RISC to the specific mRNA 
determined by sequence complementary. Once bound the mRNA will be cleaved and 
degraded (Grishok 2005). Using commercially available RNAi libraries genome-wide 
RNAi screening is feasible (Kamath and Ahringer 2003). The discovery of RNAi was 
rewarded with another Nobel Prize in Physiology or Medicine in 2006 to Craig Mello 
and Andrew Fire. A third Novel Prize for research using the nematode went to Martin 
Chalfie who shared the Nobel Prize in Chemistry in 2008. He contributed to the 
development of green fluorescent protein (GFP) as a tool for visualizing biological 
structures in living organisms by inserting the GFP gene into C. elegans. The DNA 





bombardment with microparticles (Mello et al. 1991; Praitis et al. 2001). In addition, 
many signaling pathways have been uncovered in C. elegans which are conserved in 
humans including the hypoxia signaling pathway. 
3.9 Hypoxia signaling in C. elegans 
The hypoxia signaling pathway was originally decrypted in the worm. A protein was 
identified which regulates HIF-1 through prolyl hydroxylation (Epstein et al. 2001). 
The gene that encoded this protein is called egl-9 or better known as PHD in 
humans. Nowadays it is also known that the C. elegans genome encodes one VHL 
gene (vhl-1) and a HIF-α homolog (hif-1). VHL role as a substrate-recognition subunit 
of an E3 ubiquitin ligase regulating HIF is entirely conserved (Epstein et al. 2001; 
Jiang et al. 2001). Further studies showed, that the activation of HIF mediates 
longevity in C. elegans (Mehta et al. 2009; Müller et al. 2009). This longevity caused 
by HIF is independent of the insulin/IGF-1/FOXO pathway. The insulin/IGF-1/FOXO 
pathway was the first lifespan pathway that was discovered in the worms (Kenyon et 
al. 1993). Today, many other pathways and genes were found to be involved in the 
lifespan of C. elegans including TOR signaling, Sirtuins and AMP-activated protein 






AKI can lead to ESRD and loss of kidney function. Possible approaches to prevent 
AKI are addressed by the concept of preconditioning protocols. These protocols are 
based on activating innate stress response pathways to protect renal tissue against 
AKI. One of these preconditioning protocols relies on the activation of the hypoxia 
signaling pathway. However, none of the preconditioning protocols have yet made 
their way into a clinical setting. To increase the understanding of the molecular 
mechanisms behind hypoxic preconditioning, we set out to further elucidate the 
hypoxia signaling pathway focussing on RBPs in a simple model organism. Thus, the 
overall aim of the thesis was to investigate the impact of the hypoxia signaling 
pathway on the global RBP landscape. Since we had successfully used vhl-1(ok161) 
mutant worms previously as a model to constitutively activate HIF, C. elegans was 
our choice of model organism to address this complex biological question. 
 
Hence, to investigate the impact of the hypoxia signaling pathway on the global RBP 
landscape, we focused our work on the following objectives: 
• To conduct RIC in wild-type and vhl-1(ok161) mutant worms 
• To describe a comprehensive RBPome based on these data 
• To identify novel RBPs 
• To analyse the impact of hypoxia signaling on RNA-protein interactions 
• To characterize the role of RBPs identified in lifespan regulation 
• To create worm strains allowing for the identification of the RNA targets of 
these RBPs 
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4 Materials and Methods 
4.1 Materials 
4.1.1 Used materials 
Table 1: List of materials used. 
Materials Product Number Company 
Blotting Paper / Grade BF 4 FT-2-521-110170G Sartorius 
Bis-Tris gel, 4% to 12% 1.0 mm, 
Mini Protein Gel, 12-well 
10247002 Thermo Fischer Scientific 
Carl Roth™ Opaque Blue 
Disposable Antistatic Polystyrene 
Weighing Trays 
10057602 Fischer Scientific 
Centrifuge tubes, Falcon® (15 ml) 734-0451 VWR 
Centrifuge tubes, Falcon® (50 ml) 734-0448 VWR 
CryoPure Tube 1.0ml white 72.377 Sarstedt 
Empty Gel Cassette Combs, mini, 
1.0 mm, 10 well 
NC3010 Thermo Fischer Scientific 
Empty Gel Cassettes, mini, 1.0 mm NC2010 Thermo Fischer Scientific 
Microtubes (1.5 ml) 72.690.001 Sarstedt 
Femtotips®, injection capillary, 
sterile, set of 20 
930000035 Eppendorf 
Immobilon-P PVDF membrane T831.1 Roth 
Lid chain, flat 65.989.002 Sarstedt 
Micro tube 1.5ml 72.690.001 Sarstedt 
MicroAmp™ Fast Optical 96-Well 
Reaction Plate, 0.1 mL 4346907 Thermo Fischer Scientific 
Microscope Slide 76 x 26 mm 11102 Engelbrecht 
Multiply®-µStrip 0.2ml chain 72.985.002 Sarstedt 
Parafilm M laboratory film PM996 Bemis 
Pasteur pipettes 612-1701 VWR 
Petri dish 60x15mm with cams 82.1194.500 Sarstedt 
Petri dish 92x16mm with cams 82.1473.001 Sarstedt 
Polypropylene Bottle (250 ml) 334205 Beckman Coulter 
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Polypropylene Bottle (1000 ml) A98812  Beckman Coulter 
Platinum Wire 0.2 mm diameter/ 
99.9% 
900543 CHEMPUR 
Pipette bulbs 612-2693 VWR 
Peha-soft® nitrile white powder-free 9422083 Hartmann 





Rotilabo® disposable weighing 
pans, opaque blue, anti-static (100 
ml) 
2150.1 Roth 
Rotilabo® disposable weighing 
pans, opaque blue, anti-static (330 
ml) 
2159.2 Roth 
Safe Lock Tubes 1.5 ml 0030120086 Eppendorf 
Semi-micro cuvette, PS 67.742 Sarstedt 
Strippettes (5 ml) 4051 Corning 
Strippettes (10 ml) 4101 Corning 
Strippettes (25 ml) 4251 Corning 
Yellow Bevelled Tip 10 µl (Sterile), 
Racked S1111-3810-C Starlab 
Yellow Bevelled Tip 1000 µl 
(Sterile), Racked S1111-6811-C Starlab 
Yellow Bevelled Tip 200 µl (Sterile), 
Racked S1111-1816-C Starlab 
4.1.2 Devices 
Table 2: List of devices used. 
Instrument Product Number Company 
Centrifuge 5810/ 5810 R 5811000620 Eppendorf 
Drying / heating oven  T 6030 300 Heraeus 
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EnSpire Multimode Plate 
Reader 






Chemiluminator 60-FU-SOLO PeqLab 




system size S 40-0708 PeqLab 
Homogeniser 432-3750 VWR 
Horizontal Electrophoresis 
system size L 40-1214 PeqLab 
LED light source KL 1500 LCD Schott 
Magnet 12321D Thermo Fischer Scientific 
Mediaclave 10/30 - Integra 
Mediajet, Petri Dish Filler - Integra 
Minicentrifuge 521-2844 VWR 




Microscope Observer.A1 - Zeiss 
micro injector (FemtoJet) 5252000013 Eppendorf 
MIR Cooled Incubators  MIR-154-PE Phcbi 
NanoDrop 
Spectrophotometer 1000 PeqLab 
Precision balance PCB PCB 1000-2 Kern 
Reax top Vortex 541-10000-00 heidolph 
Scanner Perfection V800 B11B223401 Epson 
Materials and Methods 
18 
 
Sonicator/Bioruptor Pico B01060010 Diagenode 
Sonopuls 3665 Bandelin 
Spectrophotometer 80-3003-75  Biochrom 
Stereomicroscope MDG35 Leica 
Tissue grinder, 7 ml 357424 Wheaton 
Thermal Cycler S100 Biorad 
ThermoShaker 846-051-500 Analytikjena 
Tube roll mixer SRT6 9.728 810 Häberle 
UV Transilluminator Ti5 Biometra 
Vortex Reax top 541-10000-00 Heidolph 




EI0001 Thermo Fischer Scientific 
4.1.3 Chemicals and reagents 
Table 3: List of chemicals and reagents used. 
Chemicals/Reagents Product Number Company 
Agar 11396.03 Serva 
Agarose A9539 Sigma 
Ampicillin RO/K0291.000100 Roth 
Ampuwa (Water) 7610894 Fresenius 
Bacto Peptone 211820 BD 
Bovine Serum Albumin (BSA) A7030 Sigma 
Bromphenol blue A2331 Applichem 
Calcium chloride 5239.1 Roth 
Carbenicillin 6344.2 Roth 
Cholesterol C8667-5G Sigma 
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cOmplete™, EDTA-free Protease 
Inhibitor Cocktail (PIM) 
11873580001 Merck 
dNTP set 100 mM R0181 Thermo Fischer  
Dithiothreiol (DTT) 6908 Applichem 
Ethanol 9065 Roth 
Ethidium Bromide Solution (1%) 2218.1 Roth 
Ethylenediaminetetraacetic acid 
disodium salt dihydrate (EDTA) 
E5134 Sigma 
Gene Ruler 1 KB DNA Ladder SM0311 Thermo Fischer 
Scientific 
Gene Ruler 50 bp DNA Ladder SM0372 Thermo Fischer 
Scientific 
Glycerol 3783 Roth 
GoTaq G2 Flexi DNA Polymerase M7801 Promega 
GoTaq® Reaction Buffers M7911 Promega 
Halocarbon oil 700 H8898-50ML Sigma 
Hydrochloride acid 2 N T134 Roth 




LB-Agar X965 Roth 
LB-Medium X964 Roth 
Lithium chloride (LiCl) L9650-500G Merck 
Lithiumdodecyl sulphate (LDS) CN25.1 Roth 
Loading Dye Solution 6x R0611 ThermoFischer 
Scientific 
Magnesium chloride (MgCl2) KK36.1 Roth 
Magnesium sulfate heptahydrate 
(MgSO4 7H2O) 
105886 Merck 
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Nystatin (10 mg/ml) 475914 Calbiochem 
PageRuler plus Prestained Protein 
Ladder 
26619 Thermo Fischer 
Potassium chloride (KCL) 6781.1 Roth 
Pure acetic acid 99% - 100% 7332 Roth 
RNase-free Water Ultra Pure 10977-035 Invitrogen 
Sodium Azide S2002 Sigma 
Sodium Chloride S5886 Sigma 
Sodium dodecyl sulfate (SDS) CN30  Roth  
Sodium hydroxide solution 2N T135 Roth 
Tris Hydrochloride (HCl) 9090.3 Sigma 
Trizma (Tris base) 93352-100G Merck 
TRIzol Reagent 15596018 Thermo Fischer 
Tween-20 3472 Caesae&Lorentz 
5-Fluoro-2′-deoxyuridine (FUDR) F0503 Merck 
4.1.4 Kits 
Table 4: List of Kits used. 
Kit/Assay Product Number Company 
Pierce™ BCA Protein 
Assay Kit 
23225 Thermo Fischer 
Direct-zol RNA Miniprep R2051 Zymo Research 
Pierce™ Silver Stain Kit 24612 Thermo Fischer 




Table 5: List of buffers used. 
Buffer Composition 
NP40 Washing buffer 50 mM Tris pH 7.5 
 140 mM LiCl 
 2 mM EDTA pH 8 
 0.5% NP40 
 0.5 mM DTT 
Laemmli 2X 150 mM TrisHCl pH 6,8 
 4% SDS 
 20% Glycerol 
 0.002% Bromophenol blue 
 0.1 M DTT 
Lysis Buffer 100 mM Tris pH 7.5 
 500 mM LiCl 
 10 mM EDTA pH 8 
 1% LiDS 
 5 mM DTT 
 1 Tablet Protease inhibitor per 50 ml 
S Medium 1 l S Basal 
 
10 ml 1 M potassium citrate pH 6 
10 ml trace metals solution 
 
3 ml 1 M CaCl2 
3 ml 1M MgSO4 
 1 ml Cholesterol 
S Basal 5.85 g NaCl 
 1 g K2HPO4 
 6 g KH2PO4 
 1 ml Cholesterol 
 H20 to 1 l 
Trace metals solution 1.86 g disodium EDTA 
 0.69 g FeSO4*7 H2O 
 0.2 g MnCl2*4 H2O 
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 0.29 g ZnSO4*7 H2O 
 0.025 g CuSO4*5 H2O 
 H2O to 1 l 
Bleach solution 0.4 N NaOH 
 7.5% NaClO 
TAE Buffer 22 mM Tris 
 10 mM Acetic acid 
 1 mM Na2 EDTA 2*H2O 
 0.0005% Ethidium bromide 
Western blot Running Buffer 25 mM Tris 
 192 mN Glycine 
 0.1% (W/V) SDS 
 pH 6.8 
Western blot Transfer Buffer 25 mM Tris 
 188 mM Glycine 
 0.1% (W/V) SDS 
Western blot Wash Buffer 30 mM Tris 
 300 mM NaCl 
 0.3% (V/V) Tween20 
 pH 7.5 
Freezing solution 100 mM NaCl 
 50 mM KH2PO4 
 3.26 M Glycerol 
 300 M MgSO4 
NGM Agar Plate  2.5 mM Becto Peptone 
 53 mM NaCl 
 52 mM Serva Agar 
 H20 
 autoclave 
 1 mM CaCl2 
 1 mM MgSO4 
 0.013 mM Cholesterol 
 25 mM KPO4 
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 100 units/ml Nystatin 
RNAi Plates 2.5 mM Becto Peptone 
 53 mM NaCl 
 52 mM Serva Agar 
 autoclave 
 1 mM CaCl2 
 1 mM MgSO4 
 0.013 mM Cholesterol 
 25 mM KPO4 
 100 units/ml Nystatin 
 100 µg/ml Carbenicillin 
 4 mM IPTG 
M9 buffer 1 mM MgSO4 
 22 mM K2HPO4 
 52 mM Na2HPO4 
 85 mM NaCl 
 in H2O 
LB medium 4 g LB Medium 
 in 200 mL H2O 
Base solution 0.025 N NaOH 
 0.2 mM EDTA 
 pH 12 
Neutralization solution 40 mM Tris-HCl pH 5 
ECL Detecting Solution 100 mM Tris 
 1.25 mM Luminol 
 0.20 mM Coumeric acid 
 0.75 % (V/V) H2O2 
 pH 8.5 
4.1.6 Software 
Table 6: List of Software used. 
Software Version Provider 
Perseus 1.6.2.2 https://maxquant.net/perse
us/ 
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Graph pad prism 6.07 https://www.graphpad.com
/ 
Fiji 2020-02-25 15:47 https://imagej.net/Fiji 
Excel Microsoft Office 
Professional Plus 2016 
https://www.office.com/?o
mkt=de-DE 
MaxQuant 1.5.3.8 https://www.maxquant.org/ 
R 3.4.4 https://www.r-project.org/ 
4.1.7 Beads used 
Table 7: List of used beads. 






















44152105050250 GE Healthcare Mass Spectrometry 
4.1.8 Antibodies 
Table 8: List of antibodies used. 
Antigen Catalog Number Provider Dilution Usage 




IgG Mouse 115-035-003 Dianova 1:30000 Western Blot 
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4.1.9 Worm strains 
Table 9: List of worm strains used. 
Strain Name Genotype Source 
WTN2 - CGC 
TMB032 vhl-1(ok161) X Nephrolab 
CB1370 daf-2(e1370) III CGC 
TMB087 pqn-53::3xFLAG Nephrolab 
4.1.10 RNAi used 
Table 10: List of RNAi used. 
RNAi against Sequence Name Source 
EV - Nephrolab 
GFP - Nephrolab 
daf-2 Y55D5A.5 Nephrolab 
daf-16 R13H8.1 Nephrolab 
atad-3 F54B3.3 Ahringer library 
C46F11.4 C46F11.4 Ahringer library 
R148.5 R148.5 Ahringer library 
cdk-11.1 B0495.2 Ahringer library 
F42G8.10 F42G8.10 Ahringer library 
M28.5 M28.5 Ahringer library 
4.1.11 Oligonucleotides used 
Table 11: List of oligonucleotides used. 
Primer name Sequence (5´->3´) Usage 
 





















pqn-53 crRNA CATCAACTCGTACACAATCAAGG CRISPR-Cas9 injection 
mix 






vhl-1 fp TCATAAACCGCTGTCAATCG Genotyping PCR 
vhl-1 rp AAAACGACCGTATGGGGAAT Genotyping PCR 
vhl-1 fp ATCATCCATGGGTTGCTAGG Genotyping PCR 
L4440 fp CAGTGAGCGAGGAAGCAA RNAi sequencing 
L4440 rp AAAACGACGGCCAGTGAG RNAi sequencing 
4.2 Methods 
4.2.1 Worm maintenance 
4.2.1.1 Culturing of C. elegans 
Worms were cultured on NGM agar plates seeded with E. coli strain OP50 at 20°C 
using standard techniques as described before (Brenner 1974). 
4.2.1.2 Culturing of Escherichia coli bacteria 
Escherichia coli (E. coli) bacteria were cultured in LB medium overnight on a shaker 
at 37°C and seeded on NGM agar plates. For the C. elegans liquid culture, bacteria 
were harvested when an OD of 0.8 was measured in 1 liter LB medium to have them 
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in the exponential phase. For long term storage 800 µl of a bacteria overnight culture 
were mixed with 200 µl Glycerol in a 1 ml cryotube and stored at -80°C. 
4.2.1.3 Freezing worms 
Starved L1 larvae were frozen at –80°C for storage. 2 ml of freezing solution mixed 
with 2 ml of M9 buffer were used to wash the worms from the plates, the larvae were 
then aliquoted in cryotubes (1 ml) and stored at -80°C. 
4.2.1.4 Egg prep 
Axeniziation is a method commonly used to remove bacterial and fungal 
contaminations and to synchronize a nematode population. Adult gravid worms were 
collected either from plates or from liquid culture and were washed in M9 buffer. The 
worms were then incubated with Bleach solution until complete lysis (approx. 5 min 
confirmed under a stereo microscope). After adding M9 buffer to partly neutralize the 
solution, the mixture was centrifuged at 400 x g for 2 minutes. The supernatant was 
discarded and the pellet containing the isolated eggs was washed three times with 
M9 buffer. After washing the eggs were either transferred on OP50 seeded NGM 
dishes, or on non-seeded dishes for L1 synchronization or directly added to a liquid 
culture. 
4.2.1.5 Worm lysis for genotyping 
A single worm was transferred to 11 µl of base solution and incubated at 95°C for 30 
minutes. To stop the lysis 11 µl of neutralization solution was added and the lysate 
was stored at -20 °C. 
4.2.1.6 Feeding RNAi expressing bacteria 
RNAi by feeding is commonly used to down-regulate gene expression in nematodes 
(Fire et al. 2007). The RNAi expressing bacteria, E. coli strain HT115 was cultured in 
LB medium containing 100 µg/ml ampicillin and 10 µg/ml tetracycline at 37°C, 
shaking. The bacteria were then seeded on RNAi NGM agar plates containing 1 mM 
IPTG and 100 µg/ml Carbenicillin. IPTG induces the activation of the two inverted T7 
promoters and by this the expression of double-stranded RNA (Timmons et al. 2001). 
As a technical control for each RNAi experiment, worms ubiquitously expressing psur-
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5::GFP were fed with bacteria expressing empty vector RNAi and GFP RNAi, and 
visually screened at a fluorescence microscope (Axio Zoom) for GFP levels. 
4.2.1.7 C. elegans Lifespan Machine 
Setup 
The Lifespan Machine is a scanner-based system able to observe and compute the 
lifespan of C. elegans (Stroustrup et al. 2013). This machine consists of hardware 
and software parts. The hardware parts are modified flatbed scanners and glass 
plates including rubber mask. In our laboratory, 10 Epson v800 scanners were set up. 
Differently than what described by Stroustrup et al. 2013, we installed two long lateral 
fans on each scanner instead of eight small fans. The rubber masks used on each 
scanner were made for 60 mm dishes at a size to harbor 14 dishes (Figure 24). The 
software part consists of the acquisition server, the analysis server and the website. 
For the acquisition server, we used the version 2.3 (from 
http://lifespanmachine.crg.eu/lsm/) on a laptop with a Linux operating system. To 
increase the calculation speed the analysis software was run simultaneously on 
multiple computers with windows 10 as the operating system. The lifespan machine 
website is the interface between the acquisition server and the analysis server. It 
manages the data storage and schedules data processes. 
Experiments 
For each lifespan experiment, 35 young adult worms were transferred to 60 mm 
NGM or RNAi plates containing 150 µM Fluorodeoxyuridine (FUdR) to inhibit 
reproduction. For each strain at least 3 plates were used. The plates were put upside 
down without the lids on the scanner glass plates, sealed by the rubber mask to 
prevent desiccation. The glass plates were then placed in the scanner, and a first 
scan was taken to make sure the plates and the worms were scanned correctly. With 
this scan, the position of each plate was defined and the complete experiment could 
then be started. The scan interval was set to 30 minutes. After the first three scans 
were finished the masking which splits the acquired images into per plate pictures 
was applied. Following the worm detection could be started. When all worms were 
dead the storyboard was created. The storyboard visualizes each worm detected on 
the plates over time. At this step, each worm image was manually checked and was 
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censored when there was any discrepancy (usually not a worm or worm was still 
alive). The final death events of the worms were collected in a table. 
Analysis 
The lifespan machine results are summarized in a table containing all information 
collected during the complete experiment. This information comprises device name, 
experiment name, plate name and location, strain name, age at death, and censored 
worms. To visualize the data in a graph we used the following information: strain 
name and age at death. The graph was generated using the graph pad prism 
software version 5.04. All of the lifespans performed in this work are summarized in 
Table 12. 
Table 12: Summary of Lifespan results. 






Figure 26 A wild-type - 349 20 
Figure 26 B wild-type - 58 16.5 
Figure 26 B vhl-1(ok161) - 84 20 
Figure 26 C wild-type - 70 21 
Figure 26 C daf-2(e1370) - 242 46 
Figure 27 A wild-type empty vector 88 16.5 
Figure 27 A wild-type daf-2 163 27.5 
Figure 27 B wild-type empty vector 115 18.5 
Figure 27 B wild-type daf-16 36 11 
Figure 28 A wild-type Empty vector 69 17.14 
Figure 28 A wild-type daf-2 65 28.10 
Figure 28 A wild-type atad-3 66 21.66 
Figure 28 A wild-type C46F11.4 59 21.66 
Figure 28 A wild-type R148.5 77 20.83 
Figure 28 A wild-type F42G8.10 51 23.35 
Figure 28 A wild-type M28.5 57 19.94 
Figure 28 A wild-type cdk-11.1 54 20.16 
Figure 28 A wild-type tat-5 54 16.79 
Figure 28 A wild-type pfd-5 53 17.18 
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4.2.2 Molecular techniques 
4.2.2.1 Genotyping PCR 
The desired DNA fragments were amplified by PCR. For the genotyping of vhl-
1(ok161) mutants, three primer approach was used whereas for pqn-53::3xFlag 
worms two primer approach were used. The following protocol was performed: 
Table 13: Pipetting scheme for genotyping PCR. 
ddH2O 13.35 µl 
5xGotaq Buffer 5 µl 
25 mM dNTPs 0.2 µl 
25 mM MgCl2 1.5 µl 
5 µM Primer 1 1.25 µl 
5 µM Primer 2 1.25 µl 
5 µM Primer 3 or ddH2O 1.25 µl 
Worm lysate 1 µl 
Gotaq 5 u/µl 0.2 µl 
Total volume 25 µl 
 
The following PCR program was used on a standard thermocycler: 
Table 14: Genotyping PCR program. 
95°C 95 min. 
95°C 30 sec. 
55°C 30 sec. x 30 Cycles 
72°C 45 sec. 
72°C 5 min. 
10°C ∞ 
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4.2.2.2 Gel electrophoresis 
Table 15: Agarose gel ingredients. 
 2% Gel 
Agarose 2 g 
TAE-buffer 100 ml 
Ethidium bromide 1% 1 μl 
 
The products of the genotyping PCRs were analysed by electrophoresis on 2% 
agarose gel. The size was estimated using the appropriate DNA ladder. 
4.2.2.3 C. elegans genome editing using CRISPR-Cas9 
The CRISPR-Cas9 protocol was performed as already described (Paix et al. 2017). 
Briefly, the strategy consists of a guide RNA (crRNA) that will guide Cas9 protein to 
the target sequence and a repair template (single-stranded oligodeoxynucleotide 
(ssODN)) containing homology arms corresponding to the gene and a FLAG tag. We 
designed a crRNA and an ssODN for the pqn-53 gene. The pqn-53 ssODN consists 
of the nucleotide sequence corresponding to a triple FLAG (3xFLAG) tag. The 
3xFLAG tag sequence is flanked 5´and 3´by 30 nucleotide long homology arms 
corresponding to parts of the pqn-53 gene sequence. Besides, dpy-10 gene guide 
RNA and DNA repair template were designed to allow the identification of 
successfully injected hermaphrodites. The injection was performed as described 
before (Evans 2006). Briefly, five worms day one adults were placed on a coverslip 
with a 2% agarose pad on it, and were covered with a layer of Halocarbon oil to 
prevent drying during the process. The injection needle was filled with the CRISPR-
Cas9 mix and positioned to inject worms. Injections were performed on a microscope 
(Observer.A1) connected to an electronic microinjector (FemtoJet) with a 
magnification of 40x. 
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Table 16: CRISPR-Cas9 injection mix. 
Cas9 (10 µg/µl) 5 µl 
tracrRNA (4 µg/µl) 5 µl 
dpy-10 crRNA (8 µg/µl) 0.3 µl 
dpy-10 ssODN (500 ng/µl) 0.3 µl 
pqn-53 crRNA (8 µg/µl) 0.5 µl 
pqn-53 ssODN (500 ng/µl) 1 µl 
KCl (1 M) 0.3 µl 
HEPES pH 7.4 0.3 µl 
H2O 7.3 µl 
 
For each construct, 50 worms were injected in one of the two gonads and afterward 
placed on a single plate seeded with OP50, and incubated at 20 °C for several days. 
After 2 days, the plates were screened for the presence of roller and dumpy 
phenotypes in the F1 generation, caused by editing events in the gene dpy-10 and 
an indication of successful injection. The F1 worms from the selected plates were 
singled on new plates and grown till they laid eggs. Next, the genotyping PCR was 
performed on the F1 generation and the F2 worms were selected based on the 
results of the PCR. After the F2 generation laid eggs they were genotyped and FLAG 
tag homozygous worms were isolated. Sanger sequencing was used to screen and 
confirm the integration of the triple FLAG tag after CRISPR based genome editing. 
For that reason, the following reaction was performed. 
Table 17: Sequencing mix. 
BigDye® Terminator 0.25 µl 
BigDyeTM Terminator buffer 2.25 µl 
pqn-53 fp or pqn-53 rp (1:1000 of 100 pmol/µl) 2 µl 
Worm lysate 1 µl 
ddH20  4.5 µl 
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Table 18: Sequencing reaction cycling conditions. 
Temperature (°C) Time 
96 60 sec 
96 10 sec 
55 5 sec 40 cycles  
60 4 min 
10 ∞ 
 
The samples were then submitted to the Cologne Center for Genomics (CCG). 
4.2.2.4 Western blot 
Western blot analysis was used to confirm the integration, expression and size of 
triple FLAG after CRISPR injection. First, 50 worms were picked into 1 ml lysis buffer 
and sonicated (Sonopuls) ten times for 30 seconds. Afterward, 2xLaemmli buffer was 
added and the sample was incubated for 5 minutes at 95°C. 30 µl of the samples 
were loaded on a 4 to 12% Bis-Tris polyacrylamide gel and the gel was run at 200 V 
constant for 60 minutes. The PVDF membrane was activated before by incubation for 
30 seconds in methanol. Meanwhile, the gel and the two filter papers were soaked in 
transfer buffer. Next, the gel was transferred into a transfer chamber were a sandwich 
was built with the following order from bottom to top: filter paper, PVDF membrane, 
Gel, filter paper. The transfer was run at 12 V for 60 minutes. The membrane was 
incubated with a blocking solution (4% BSA in wash buffer) for one hour. Then the 
membrane was washed three times with wash buffer and incubated for 1 hour with 
the first antibody (1:10000) recognizing the FLAG tag. After another washing round of 
three times the membrane was incubated for 1 hour with the horseradish peroxidase 
(HRP) labeled secondary antibody (1:30000) recognizing the FLAG tag. Finally, the 
membrane was washed three times and overlaid with100 µl Femto Luminol buffer. 
That leads to oxidizing luminol in the presence of HRP resulting in 
chemiluminescence. The chemiluminescence was visualized using a 
chemiluminescence imaging system (Fusion solo). 
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4.2.2.5 RNA interactome capture (RIC) 
For each liquid culture, 300.000 worms were grown in 300 ml of growth medium. The 
growth medium was prepared by resuspending an OP50 bacterial pellet obtained 
from 1 liter OD 0.8 bacteria culture in S Medium. Isolated eggs were added to the 
mixture, and incubated at 20°C, shaking at 120 rpm for 72 hours. Young adult worms 
were harvested and washed three times in M9 buffer. After settling down in a 50 ml 
tube on ice, the supernatant was discarded and the worms were transferred to an 
empty NGM plate. Half of the worms (150.000) were irradiated with UV-C (254 nm) at 
300mJ/cm² (Stratalinker 1800). Afterwards the worms were collected in M9 buffer and 
resuspended in lysis buffer. The non-crosslinked worms (150.000) were directly 
resuspended in lysis buffer. Worm lysates were prepared using a dounce 
homogenizer performing fifty strokes for each sample and checking at the 
stereomicroscope for complete homogenization. The lysates were directly used for 
RNA interactome capture and a fraction of the same lysate for proteome analysis. A 
total of 18 samples were created (Table 19). RIC was performed as previously 
described (Ignarski et al. 2019), and adapted to C. elegans. The lysate was 
incubated with 2 ml oligo(dT) magnetic beads, rotating for 1 hour at 4°C. The beads 
were collected on a magnet and the supernatants were saved for two additional 
rounds of depletion. Beads were then washed three times with 10 ml lysis buffer, 
three times with 10 ml washing buffer and once with 10 ml washing buffer without 
NP40. After the last wash the beads were resuspended in 300 µl elution buffer and 
incubated at 80°C for 2 minutes. The protocol was repeated three times in total and 
the three eluted fractions were combined. An aliquot from each sample was taken to 
measure RNA concentration. To remove RNA before mass spectrometry and silver 
gel analysis, the combined fractions were treated with 10 U/ml RNAse I and 125 U/ml 
Benzonase at 37°C for 3 hours. After that, 2% of each eluate was loaded together 
with 0.01% of the lysate (taken after homogenizing) on a 4 to 12% Bis-Tris gel. The 
gel was run at 200 V constant for 60 minutes and was incubated afterwards with 
silver staining. RNA concentration was measured using a Qubit™ RNA HS Assay Kit. 
Protein concentration was measured using BCA assay. Protocols were performed as 
described in the manual (PierceSilver Stain Kit, Qubit™ RNA HS Assay Kit, 
PierceBCA Protein-Assay). 
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4.2.3 Mass Spectrometry 
4.2.3.1 Protein preparation for mass spectrometry 
All protein samples origin from RIC and the whole worm lysate samples were 
prepared for mass spectrometry using carboxylate modified paramagnetic beads 
(SP3) according to the published protocol (Hughes et al., 2014). Briefly, samples 
were reduced in 5 mM dithiothreitol (DTT) incubating at 55°C for 30 min. Reduced 
cysteine residues were alkylated by adding chloroacetamide (CAA) to 40 mM for 30 
minutes at room temperature in the dark. The samples were then centrifuged for 10 
minutes at 20,000 x g and the supernatants were transferred to a new tube. 
Hydrophilic and hydrophobic Sera-Mag carboxylate-modified magnetic particles (GE 
Healthcare) were combined 1:1, washed two times with 10 volumes of water and 
resuspended at a concentration of 10 µg/µl with water. 2 µl of the beads mix was 
added to the samples and acetonitrile (ACN) was added to a final percentage of 
50%. The mixture was incubated at room temperature for 8 minutes and placed on a 
magnetic rack for 2 minutes. Supernatants were removed and the beads were 
washed twice with 200 µl of 70% Ethanol (EtOH) and once with 100% ACN. The 
beads were air dried and reconstituted in 5 µl 50mM triethylammonium bicarbonate 
(TEAB) containing 0.5 µg trypsin and 0.5 µg LysC. Proteins were digested for 16 
hours at 37°C. The beads were resuspended by pipetting up and down and ACN was 
added to 95 % final. The mixture was incubated at room temperature for 8 minutes 
and placed on a magnetic rack for 3 minutes. Supernatants were removed and the 
beads were washed twice with 200 µl of 100% ACN. Peptides were eluted from the 
beads by the addition 9 µl 4% dimethyl sulfoxide (DMSO) and sonication for 5 
minutes. Samples were placed on a magnetic rack and the supernatants were 
transferred to new tubes. This step was repeated once to ensure the complete 
removal of magnetic beads. Peptides were acidified by the addition of 1 µl 10% 
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4.2.3.2 LC-MS Acquisition 
All samples were analysed on a Q Exactive Plus Orbitrap (Thermo Scientific) mass 
spectrometer that was coupled to an EASY nLC LC (Thermo Scientific). Peptides 
were loaded onto an in-house packed analytical column (50 cm — 75 µm I.D., filled 
with 2.7 µm Poroshell EC120 C18, Agilent) that was operated at a constant flow rate 
of 250 nl/min at 50°C. Depending on the experiment type, one of three different 
chromatographic gradients was used. 240 min: 4-5% solvent B (0.1% formic acid in 
80% acetonitrile) within 1.0 min, 5-28% solvent B within 200.0 min, 28-50% solvent B 
within 28.0 min, 50-95% solvent B within 1.0 min, 150 min: 3-5% solvent B (0.1% 
formic acid in 80% acetonitrile) within 1.0 min, 5-30% solvent B within 119.0 min, 30-
50% solvent B within 19.0 min, 50-95% solvent B within 1.0 min 90 min: 3-5% solvent 
B (0.1% formic acid in 80% acetonitrile) within 1.0 min, 5-30% solvent B within 65.0 
min, 30-50% solvent B within 13.0 min, 50-95% solvent B within 1.0 min. All gradients 
included final wash and column equilibration steps. Depending on gradient length, 
peptide precursors were dynamically excluded for 40.0 s, 25 s or 15 sec.  MS1 
survey scans were acquired from 300-1750 m/z at a resolution of 70,000. The top 10 
most abundant peptides were isolated within a 1.8 Th window and subjected to HCD 
fragmentation at a normalized collision energy of 27%. The AGC target was set to 
5e5 charges, allowing maximum injection times of 60 ms (240 min and 150 min 
gradients) or 100 ms (90 min gradient). Product ions were detected in the Orbitrap at 
a resolution of 17,500. 
4.2.3.3 Data analysis and statistics 
Protein identification: all mass spectrometric raw data were processed with 
MaxQuant (version 1.5.3.8) using default parameters. Briefly, MS2 spectra were 
searched against the Uniprot CAEEL.fasta database (downloaded the 16.6.2017), 
including a list of common contaminants. False discovery rates on protein and PSM 
levels were estimated by the target-decoy approach to 1% (Protein FDR) and 1% 
(PSM FDR) respectively. The minimal peptide length was set to 7 amino acids and 
carbamidomethylation at cysteine residues was considered as a fixed modification. 
Oxidation (M) and Acetyl (Protein N-term) were included as variable modifications. 
The match-between runs option was enabled. 
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Statistical analysis of both the whole worm proteome and the RNA interactome raw 
data was performed with the Perseus software (Tyanova et al., 2016), version 
1.6.2.2. iBAQ intensities were used in this analysis and log2 transformed. Filtering of 
proteins only identified by site, reverse proteins and potential contaminants was 
performed. 
RNA interactome: Two samples were identified as outliers based on the number of 
proteins measured, which were higher than in crosslinked samples and the results of 
PCA and hierarchical clustering (Figure 10). Indicating that these samples possibly 
contaminated during processing e.g. with the whole worm lysates and therefore 
excluded from further analyses “T-test was performed for vhl-1(ok161) crosslinked 
(n=3) versus non-crosslinked samples (n=2) and WT crosslinked (n=3) versus non-
crosslinked samples (n=2) using FDR<0.05 and s0=0.5. 
Whole Proteome: First, proteins measured at least 3 times out of 6 replicates in total 
(WT and vhl-1(ok161)) were filtered. Second, the protein amount of wild-type and vhl-
1(ok161) mutant worms were normalized by subtracting the median and adding 
x+(highest median)+1. Third, missing values were imputed by replacing them from a 
normal distribution (width 0.3, downshift 1.8) and significantly regulated proteins were 
identified using a t-test (FDR<0.05, s0=0.5). 
Categorical annotation and enrichment analysis: The UniProt IDs were annotated 
using Perseus software for Gene Ontology (GO), PFAM and SMART. Gene set 
enrichment analysis of the combined Class I and II RIC of vhl-1(ok161) and WT was 
calculated using a Fisher exact test (Perseus standard settings, FDR<0.05 (Tyanova 
et al., 2016)), and the total number of proteins identified in both RIC and Proteome 
experiments was used as background.  
Correlation analysis WT vs. vhl-1(ok161) RNA interactome: The linear regression of 
log2 fold change of WT versus vhl-1(ok161) was calculated with R (version 3.4.4) 
using the method deming() from the R package deming (version 1.4 (https://cran.r-
project.org/web/packages/deming/index.html)) which applies the method of total least 
squares. This results in the formula y = 0.7806137 + 1.095646*x with a log2 fold 
change of vhl-1(ok161) on the x-axis and values of WT on the y-axis. To get the 
proteins that are more enriched in vhl-1(ok161) or WT, we calculated the linear 
equations that define the upper and lower boundary of the interval in which 95% of all 
measurements lie, in other words, the 95% prediction interval. This interval is defined 
by multiplying the standard deviation of the regression (1.562865) by 1.96 and 
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adding or subtracting this value to the intercept of the regression line for the upper 
and lower boundary, respectively. The linear equation for the upper boundary is y = 
3.843829 + 1.095646*x, the equation for the lower boundary is y = -2.282602 + 
1.095646*x. 
4.2.3.4 Data and Software Availability 
The mass spectrometry data (Raw data and MaxQuant (version 1.5.3.8) output) have 
been deposited at the ProteomeXchange Consortium (http://www.ebi.ac.uk/pride) via 
the PRIDE (Perez-Riverol et al., 2019) partner repository with the dataset identifier 
PXD014469. An interactive online repository was created and is provided at 





5.1 RNA Interactome Capture of wild-type and vhl-1(ok161) 
5.1.1 vhl-1(ok161) modulates the length of C. elegans 
Stabilization of HIF-1 is central to hypoxia signaling and results in the transcription of 
many target genes. Although the hypoxia signaling pathway is well studied its impact 
on the global RBPome is elusive. In this study, we used C. elegans as a model to 
analyse the impact of hypoxia signaling on RBPs. We used vhl-1 mutant worms (vhl-
1(ok161)) as a model to constitutively activate HIF. Phenotypic analysis of the first 
larval stage of C. elegans revealed that vhl-1(ok161) mutants are shorter compared 
to the wild-type worms (Figure 6A). Quantification of the length confirmed the 
observed shorter length of vhl-1(ok161) mutants compared to wild-type worms 
(Figure 6B). A previous study performing developmental studies in vhl-1(ok161) 
mutant worms observed the length phenotype likewise in larvae and showed that it 
persists in the adult stage (Wen et al. 2015). Further studies from our lab revealed 
that vhl-1(ok161) shorter length is dependent on HIF-1 activation (data not shown). 
Consequently, before performing RIC in wild-type and vhl-1(ok161) mutant worms we 
analysed their RNA content. Using 500 worms for each strain we observed reduced 
RNA amount per worm in vhl-1(ok161) mutant compared to wild-type (Figure 6C). 
The RIC method is based on the pulldown of poly-adenylated RNA and the mass 
spectrometric analysis of the bound proteins. Therefore we also analysed the protein 
amount of the worms. Again, the analysis revealed that the protein amount of vhl-
1(ok161) mutant worms compared to wild-type is reduced (Figure 6D). As a result, 
the RIC experiment needs to be adjusted for the fact that the same number of vhl-





Figure 6: vhl-1(ok161) mutants are shorter and contain less RNA and protein. 
A. Representative images of L1 worms of wild-type (WT) and vhl-1(ok161) using Nomarski microscopy 
with a magnification of 40x. Scale bar represents 20 µm. B. Quantification of the length from wild-type 
and vhl-1(ok161) worms using WormSizer. Three biological replicates are shown whereas each dot 
represents the length of a single worm, magenta dots represent the mean of a single biological 
replicate and the black bar shows the mean of the three biological replicates (n = 276 for WT, n = 177 
for vhl-1(ok161)). Significance was calculated by comparing the mean value of three biological 
replicates (p = 0.0022). C. Measurement of RNA obtained from 500 wild-type (red bar) or vhl-1(ok161) 
(blue bar) worms dissolved in 700 µl TRIzol using Qbit assay. D. Measurement of protein obtained 
from 500 wild-type (red bar) or vhl-1(ok161) (blue bar) worms dissolved in 1 ml lysis buffer using BCA. 
5.1.2 Establishing RNA Interactome Capture in C. elegans 
To investigate whether the hypoxia signaling pathway modulates the RNA- protein 
interactome we established RIC in C. elegans. To obtain sufficient material 




For each biological replicate, 300.000 worms were used and split into two samples 
containing 150.000 worms each. When the worms reached the young adult stage 
they were harvested and the crucial step of crosslinking RNA and protein was 
conducted. Crosslinking was performed for one of the two samples per condition 
using a UV wavelength of 254 nm. The other sample serves as a negative control 
and is termed “non-crosslinked” from now on. Comparison of the crosslinked samples 
against the non-crosslinked samples after RIC allows for the identification of bona-
fide RBPs. The crosslinked and non-crosslinked samples were collected and stored 
frozen. After the collection of the biological replicates, all samples were mechanically 
homogenized. Next, the RNA was captured from the worm lysate by adding oligo-dT 
beads followed by several stringent washing steps. Following the elution of the 
ribonucleoprotein (RNP) complexes, the protocol was repeated twice and the pooled 
elution was RNase digested (For detailed experimental procedures see Methods). 
Finally, the proteins were digested according to the published protocol using 
carboxylate modified paramagnetic beads (Hughes et al. 2014) and loaded on a 
mass spectrometer (Figure 7). Furthermore, after oligo-dT capture RNA and protein 
measurements were performed. This will show the presence of RNA and protein at 
that specific step and thereby confirms the efficacy of the RIC setup in wild-type and 
vhl-1(ok161) mutant worms. 
 
Figure 7: Experimental workflow of RIC. 
Wild-type and vhl-1(ok161) mutant worms were grown at 20°C in liquid culture until they reached the 
young adult stage. Worms were harvested and RNA and proteins (red, orange and magenta dots) 
were crosslinked using a UV wavelength of 254 nm. Afterwards, the worms were mixed with lysis 
buffer and mechanically homogenized. 10% of the lysate was used for mass spectrometry to analyse 
the proteome. 90% of the lysate was incubated with oligo-dT beads followed by washing steps. 10% of 
the bead suspension was used for RNA measurements. The rest was RNase digested and used for 
mass spectrometry to analyse the RBPome. For the detailed experimental procedure see Methods. 




5.1.3 Analyses of RNA and protein amounts reveal functioning RIC 
We used the wild-type and vhl-1(ok161) mutant worm strains for the RIC. Previously, 
we found that the same number of vhl-1(ok161) mutant worms contain lower 
amounts of RNA and protein compared to wild-type. Since we used the same worm 
number for RIC saturation of the beads was crucial at this step. To confirm this, we 
measured the RNA amount of the samples obtained after oligo-dT capture and before 
RNase treatment (Figure 8A). Here, we analysed the crosslinked and non-
crosslinked samples of wild-type and vhl-1(ok161) mutants, respectively. Notably, 
there was no difference in RNA amount between non-crosslinked and crosslinked 
samples of either wild-type or vhl-1(ok161) mutant worms. In contrast to the RNA 
content in whole worms (Figure 6C), there was an equal amount of RNA in wild-type 
and vhl-1(ok161) mutant worm samples after pulldown indicating saturation. 
Saturation of the beads compensates the reduced content of RNA in vhl-1(ok161) 
mutant worms leading to an equal amount of RNA after pulldown (Figure 8A). Also, 
we determined the amount of proteins in the RIC samples after RNase treatment. In 
crosslinked samples, we would expect more protein compared to the non-crosslinked 
samples. Since the RIC protocol contains harsh washing steps all non-crosslinked 
proteins disengage from RNA and are washed off the oligo-dT beads. To determine 
the protein amounts in the samples we performed silver staining of a polyacrylamide 
gel loaded with 0.1% of total lysates of wild-type and vhl-1(ok161) before (Input) and 
after the RIC experiment (10% of pooled eluates) (Figure 8B). The silver staining 
revealed that all samples, wild-type and vhl-1(ok161), both crosslinked and non-
crosslinked had similar amounts of protein in the input samples. However, as 
expected, the bands distributed between 40 kDa and 130 kDa on the polyacrylamide 
gel from the eluate samples showed a higher intensity in crosslinked samples 
compared to non-crosslinked samples in both wild-type and vhl-1(ok161) mutant 
worms. This result is consistent with previous studies that performed RIC showing 
enrichment of proteins in UVC crosslinked samples compared to non-crosslinked 
samples (Castello et al. 2012; Ignarski et al. 2019; Kwon et al. 2013; Liepelt et al. 
2016). The measurement of RNA and protein amounts revealed effective crosslinking 
of RNA with protein and enriched pulldown of proteins in crosslinked samples. After 
all samples had passed this quality control step, we moved on to mass spectrometry 





Figure 8: Silver staining revealed efficient crosslinking in RIC. 
A. RNA measurement of RIC samples after precipitation. RNA was measured from wild-type (red bars) 
and vhl-1(ok161) (blue bars) crosslinked (+CL) and non-crosslinked (-CL) samples. Data are 
represented as mean ± SEM of three biological replicates. B. Image of a silver stained polyacrylamide 
gel loaded with RIC input and eluate samples after RNase treatment of wild-type and vhl-1(ok161) 
worms. Non-crosslinked samples are denoted by - and crosslinked samples are marked with +. The 
arrow indicates the RNase I band in the RNase I treated eluates. The protein ladder (M) indicates the 
protein size ranging from 25 kDa to 250 kDa. See also Esmaillie et al. 2019. 
 
5.1.4 Mass spectrometry based identification of RNA associated proteins 
From the RIC we had 3 biological replicates of crosslinked and non-crosslinked 
samples from wild-type and vhl-(ok161) mutant worms. Also, we used the whole 
lysate for proteomics of 3 biological replicates from wild-type and vhl-1(ok161) mutant 




Table 19: Overview of samples analysed by mass spectrometry. 
 wild-type vhl-1(ok161) 
Crosslinked samples 3* 3* 
Non-crosslinked samples 3* 3* 
Proteome samples 3* 3* 
*Biological replicate per genotype 
To compare these datasets to each other we analysed the mass spectrometry data of 
all samples together and processed them using the Perseus software package (For 
details see Methods). In total, we identified 6350 proteins. For further analysis we 
chose intensity-based absolute quantification (iBAQ) values instead of label-free 
quantitation (LFQ) values since we expected large differences regarding the number 
of proteins measured between crosslinked and non-crosslinked samples. This would 
have caused the LFQ-based normalization to exclude a large number of hits since 
the LFQ approach uses the whole dataset for normalization whereas iBAQ does not. 
After logarithmization of the iBAQ values into log2 values, we first checked the whole 
worm proteome. For the proteome analysis we removed proteins if they were not 
measured at least in 3 samples out of 6 (wild-type and vhl-1(ok161)). This filtering 
step resulted in 5759 proteins identified. For the identification of significantly 
regulated proteins of vhl-1(ok161) mutants compared to wild-type, we used a t-test 
with an FDR≤0.05 and s0=0.5. This resulted in 162 proteins that were significantly 
regulated in vhl-1(ok161) mutants compared to wild-type. s0 is a feature in Perseus 
that – on top of p-values - takes the protein fold changes into account, i.e. proteins 
with a good p-value but minimal fold change will not reach the threshold. Further 
analysis of the whole worm proteome of wild-type and vhl-1(ok161) revealed that 
there is a shift of proteins in direction to wild-type in the volcano plot (Figure 9A), 
indicating that there was more protein in the wild-type samples compared to vhl-
1(ok161) mutants potentially due to the higher protein content. The higher protein 
amount in the sample is explained by the higher protein amount in a single wild-type 







Figure 9: Normalization and imputation of wild-type and vhl-1(ok161) proteome. 
Volcano plots showing log2 FC change of vhl-1(ok161) proteome compared to the wild-type proteome 
(x-axis) against the –log10 p-value of the vhl-1(ok161) proteome compared to the wild-type proteome 
(y-axis). A. Shows the proteome of vhl-1(ok161) versus wild-type. B. Shows the proteome of vhl-
1(ok161) versus wild-type after normalization. C. Shows the proteome of vhl-1(ok161) versus wild-type 
after normalization and imputation. 
To balance the protein amount of wild-type and vhl-1(ok161) mutant worms the 
median was subtracted and x+(highest median)+1 was added. After normalization of 
the proteome data, there was no shift of proteins in direction to wild-type observed in 
the volcano plot (Figure 9B). We noticed that many proteins were measured either 
only in wild-type or vhl-1(ok161). These proteins are not visualized in the volcano 
plots. To overcome this problem we replaced the missing values with values from the 
normal distribution (Figure 9C). After analysis of the whole worm proteome, we 
checked the RBPome. To analyse the RBPome we removed all proteins that were 
measured in the proteome but not measured in at least 1 sample out of 12 




number of 6162 identified proteins was reduced after filtering to 2520 identified 
proteins for the RBPome. 
 
5.1.5 RNA interactome capture data analysis and quality control 
We identified 2520 proteins in the RBPome of 3 biological replicates including both 
genotypes wild-type and vhl-1(ok161) and both non-crosslinked and crosslinked 
samples. To further investigate the quality of the RIC data we performed a Principal 
Component Analysis (PCA). The PCA indicated a clear separation of crosslinked and 
non-crosslinked samples except for two non-crosslinked samples. These samples 
contained one replicate, which did not cluster with the other non-crosslinked samples 
of their genotype (Figure 10A). Heat map analysis confirmed the results of the PCA 
showing wild-type and vhl-1(ok161) non-crosslinked samples not clustering together 
(Figure 10B). Further analysis of the two samples showed that the number of 
identified proteins is much higher compared to their corresponding crosslinked 
samples (Figure 10C, indicated in red). Since the method is based on the enrichment 
of proteins in crosslinked samples a higher amount of proteins in the non-crosslinked 
sample is unexpected. A comparison of all RIC samples shows a high number of 
proteins identified exclusively in the two outliers (Figure 10C, Unique Proteins). 
These two samples were excluded from further analyses. To check how the exclusion 
of the two samples impacted the rest of the samples, we analysed the PCA and heat 
map without these samples. In the PCA, the genotype and the state of crosslinking 
primarily determine the separation of the individual samples as expected (Figure 
10D). In line with the PCA, the heat map showed a clear separation of UVC treated 
samples to non UVC treated samples (Figure 10E). Together the PCA and heat map 






Figure 10: RBPome sample analysis. 
A. PCA of the RIC dataset. Wild-type samples are shown in red, vhl-1(ok161) samples in blue, non-
crosslinked samples depicted by a square and crosslinked samples shown in a dot. B. Heat map 
analysis of the RIC dataset. Wild-type and vhl-1(ok161) non-crosslinked and crosslinked samples are 
shown. The iBAQ intensity scale starts from 10 (blue) over 21 (white) to 32 (red). C. Table showing the 
number of proteins measured in the RIC for each crosslinked and non-crosslinked sample of WT and 
vhl-1(ok161). Also, the unique proteins compared to any of the other RIC samples are shown for the 
non-crosslinked samples of WT and vhl-1(ok161). Samples in columns marked in red were excluded 
from further analysis. D. PCA of the RIC dataset without outliers. Colour and symbol code as in A. E. 
Heatmap analysis of the RIC dataset without outliers. Wild-type and vhl-1(ok161) non-crosslinked and 





5.1.6 Classification of proteins identified in RNA interactome capture 
For the identification of significantly regulated proteins and to further increase the 
evidence that the proteins identified were indeed RBPs we used - as for the whole 
worm proteome - a t-test with an FDR≤0.05 and s0=0.5 to compare crosslinked to 
non-crosslinked samples (Figures 11A and B). The volcano plots for both wild-type 
and vhl-1(ok161) show a clear enrichment regarding the number of proteins in 
direction to the crosslinked samples. This indicates an increased protein content in 
the crosslinked sample as shown before by the silver staining (Figure 8B) and the 
number of identified proteins in mass spectrometry (Figure 10C). We identified 721 
proteins significantly enriched in crosslinked samples compared to non-crosslinked 
samples in wild-type (Figure 11A, red marked dots) and 530 in vhl-1(ok161) (Figure 
11B, blue marked dots). Proteins in which calculation of an FDR was impossible due 
to missing values in one condition are not shown here. 
 
Figure 11: Volcano plot of wild-type and vhl-1(ok161) RBPome. 
A. Wild-type non-crosslinked versus crosslinked log2 FC was plotted against the wild-type non-
crosslinked versus crosslinked –log10 p-value. Proteins with an FDR lower than 0.05 are marked in 
red. B. vhl-1(ok161) non-crosslinked versus crosslinked log2 FC was plotted against the vhl-1(ok161) 
non-crosslinked versus crosslinked –log10 p-value. Proteins with an FDR lower than 0.05 are marked 
in blue. See also Esmaillie et al. 2019. 
We defined those proteins identified in mass spectrometry with an FDR ≤ 0.05 as 
RBPs. Nevertheless, proteins measured only in crosslinked samples and absent in 
non-crosslinked samples have no FDR. Therefore, we defined another criterion to 
include these missing proteins. We distinguish RBPs defined by the two criteria as 
Class I and Class II RBPs (Figure 12A). Class I describes proteins measured 




in the corresponding non-crosslinked sample. Class II proteins are defined by an 
FDR < 0.05. In addition to Class I and Class II we created another Class based on 
previous identification in the literature called “Other RBPs” (Figure 12A). 
 
Figure 12: Classification of the wild-type and vhl-1(ok161) RBPome. 
A. Definition of RBP classes. Proteins measured exclusively three times (out of three replicates) in the 
crosslinked samples and never in the corresponding non-crosslinked samples are in Class I. All 
proteins with a calculated FDR lower than 0.05 are in Class II. Proteins falling neither into Class I nor 
Class II but identified before in a published RBPome are in class “Other RBPs”. All other proteins were 
classified as “No evidence”. B. Proteins identified in the wild-type and vhl-1(ok161) RIC were assigned 
to their corresponding classes shown by numbers in a bar. From left to right are shown Proteins 
identified in the RIC of wild-type, vhl-1(ok161) and the merged wild-type and vhl-1(ok161) RIC data. 
The classes are color-coded as followed: Class I (yellow), Class II (orange), Other RBPs (light grey) or 
No evidence (dark grey). The number on top of each bar is the total number of proteins measured. 
See also Esmaillie et al. 2019. 
All proteins falling neither into Class I nor Class II but identified in our screen with 
previous evidence in one of the published RBPomes available to date are in the class 
“Other RBPs”. The available RBPomes used in this study include data from various 
species – i.e. human, mouse, fly and worms (Hentze et al., 2018; Ignarski et al., 
2019; Queiroz et al., 2019; Tamburino et al., 2013; Trendel et al., 2019; Urdaneta et 
al., 2019). All the other proteins identified in the RIC not falling into Class I, Class II or 
Other RBPs were classified as “No evidence” (Figure 12A). These classifications 
revealed that we identified, in wild-type, 1880 RBPs out of 2473 total identified 
proteins (Figure 12B). In vhl-1(ok161) mutants we identified 1798 out of 2219 to be 
RBPs (Figure 12B). To get an impression of the quality of our data we merged the 




and vhl-1(ok161) mutants (e.g. class I in vhl-1(ok161) and class II in WT) were 
assigned to Class II having in total 1354 RBPs assigned to Class I or Class II (Figure 
12B). 
5.1.7 Annotation enrichment analysis of proteins identified in RIC 
Using the criteria described above, more than 75% of the identified proteins in RIC 
are RBPs. To provide further evidence, we performed annotation enrichment analysis 
using the combined Class I and II RBPs of wild-type and vhl-1(ok161) (Figure 13). 
 
Figure 13: GO-term enrichment of RIC proteins. 
A. GO-term enrichment of molecular function (GOMF) using the combined Class I and II RIC of wild-
type and vhl-1(ok161). B. GO-term enrichment of biological processes slim (GOBP) using the 
combined Class I and II RIC of wild-type and vhl-1(ok161). C. GO-term enrichment of cellular 
compartments slim (GOCC) using the combined Class I and II RIC of wild-type and vhl-1(ok161). The 
number next to each bar represents the number of proteins falling into the category followed by the 




The total set of pooled proteins identified in both RIC and proteome experiments 
were used as a background. The UniProt IDs were annotated using Perseus software 
for Gene Ontology (GO), PFAM and SMART. Gene set enrichment analysis was 
calculated using the Fisher exact test (Perseus standard settings, FDR<0.05 
(Tyanova et al. 2016)). Plotting the top enriched and depleted terms of molecular 
function, biological processes slim and cellular compartment slim showed that the 
vast majority of terms is associated with RNA including mRNA binding, 
ribonucleoprotein complex, translational elongation, RNA splicing and RNA helicase 
activity (Figure 13A, B and C). We analysed the GO terms of molecular function in 
terms of RNA binding versus DNA binding in more detail. In comparison to the 
proteome, we were able to determine that the term RNA binding occurs more often in 
Class I and II proteins than in the proteome (Figure 14). In contrast the term DNA 
binding was more present in the proteome compared to the Class I and II proteins. 
 
Figure 14: Comparison of the GO terms RNA 
binding and DNA binding.  
GO-term enrichment of molecular function (GOMF) 
terms RNA binding and DNA binding using the 







Besides, we performed a domain enrichment analysis using Pfam and Smart (Figure 
15A and B). Under the most enriched domains, we identified Zink finger, PUF, Piwi 
and RRM domains which are all well known to be RNA binding domains. Taken 
together the GO-term and domain enrichment analysis showed that the proteins 






Figure 15: Domain enrichment of RIC proteins. 
A. PFAM analysis using the combined Class I and II RIC of wild-type and vhl-1(ok161). B. SMART 
analysis using the combined Class I and II RIC of wild-type and vhl-1(ok161). The number next to 
each bar represents the number of proteins falling into the category followed by the number of 
category sizes. See also Esmaillie et al. 2019. 
 
5.2 Identification of novel RBPs 
5.2.1 Comparative analysis of published RNA interactomes 
To elucidate whether our study had identified previously unknown RBPs we 
compared our list of Class I and Class II proteins with previously published datasets 
summarized by Hentze et al. (Hentze et al. 2018). These datasets comprise RIC 




RBPs in our dataset were identified in the fly, worm and yeast dataset whereas about 
50% of RBPs in our dataset were identified in mouse and human (Figure 16A). 
Combining all of these datasets 70% of the RBPs in our dataset had previously been 
identified. We wondered how the only published C. elegans RIC dataset from Matia-
Gonzales et al. overlapped with our findings and how both datasets matched to the 
combined data of human, mouse, fly and yeast. The comparison revealed that Matia-
Gonzales et al. identified 594 RBPs whereas we identified 1354 RBPs using Class I 
and II (Figure 16B). Out of the 594 RBPs identified by Matia-Gonzales et al. 364 
(61%) RBPs were included in the 1354 RBPs identified in our dataset. Both, the 
Matia-Gonzales et al. (C. elegans) dataset and our dataset have an overlap of 67% 
to the combined data of human, mouse, fly and yeast (Figure 16B). 
 
Figure 16: Comparisons of Class I and Class II RBPs with previously published RIC datasets. 
A. Bar diagram showing the number of Class I and Class II RBPs identified in the previously published 
dataset (dark grey) or not identified (light grey). B. Venn diagram depicting the overlap of Class I and 
Class II RBPs with the published C. elegans RIC and other RIC datasets. The numbers in the circles 
show the overlap of proteins with each dataset. See also Esmaillie et al. 2019. 
 
5.2.2 Comparison of RIC with novel techniques 
The limitation of the RIC experiment is the pulldown of RNA primarily with a poly-A 




contacts (Piñeiro et al. 2018). However, RIC relies on the capture of polyadenylated 
RNA. Newly developed techniques allow for purification of all RNA species and 
identification of bound proteins (Queiroz et al. 2019; Trendel et al. 2019; Urdaneta 
and Beckmann 2019). To this end, we compared our data with the data of XRNAX, 
OOPS and PTex (Figure 17A). The comparison revealed that 66% of the 1354 RBPs 
identified in our dataset were also identified as RBPs in the dataset generated by 
XRNAX, OOPS or PTex. 475 RBPs out of 1354 RBPs are found in all four datasets. 
Interestingly, of the 453 RBPs identified in our dataset that were not identified in the 
data generated by the new techniques 147 of them were identified in other RIC 
experiments. To complete the analysis we compared our data to a prediction-based 
RBP study in C. elegans (Tamburino et al. 2013). These RBPs are identified by RNA 
binding domain detection in the protein sequence. Here we found that 28% of our 
RBPs were predicted before as RBPs (Figure 17B). 
 
Figure 17: Comparisons of Class I and Class II RBPs with novel techniques and predicted 
RBPs. 
A. Venn diagram comparing 1354 Class I and Class II RBPs to 1753 RBPs identified by XRNAX, 1838 
RBPs identified by OOPS and 3032 RBPs identified by PTex (Queiroz et al. 2019; Trendel et al. 2019; 
Urdaneta and Beckmann 2019). B. Venn diagram comparing 1354 Class I and Class II RBPs to 887 
RBPs predicted by protein domain analysis in C. elegans (Tamburino et al. 2013). See also Esmaillie 






5.2.3 The identification of 270 novel RBPs in C. elegans 
The comparison of RIC experiments of various organisms as well as the comparison 
of different techniques with our RIC dataset showed a notable overlap. Next, to have 
a global view of identified RBPs in our dataset, we merged all data comparisons 
shown in Figures 16 and 17. The identified RBPs in the data used for comparison are 
based on the experimental identification of RBPs and RNA binding domain analysis. 
We showed that 1084 RBPs in our dataset had been identified as RBPs previously. 
The analysis also showed that 270 RBPs had not been known to have RNA-binding 
capacity before (novel RBPs, Figure 18). Out of the 270 novel RBPs, 92 are 
conserved in humans whereas 178 are worm specific genes.  
 
Figure 18: Identification of novel RBPs. 
The bar diagram shows the number of proteins 
previously identified as RBP (1084, dark grey) and 
novel RBPs (270, light grey). The total number of 
RBPs (1354) identified in this study is displayed on 









5.3 Proteome analysis of wild-type and vhl-1(ok161) 
5.3.1 Proteome data analysis and quality check 
The analysis of wild-type and vhl-1(ok161) RIC led to the identification of RBPs in 
both conditions. We were able to distinguish known RBPs from novel RBPs. In the 
next step, we wanted to know how the activation of hypoxia signaling alters the 




actual basis to comparing the individual RBPomes. We used aliquots from the RIC 
input samples and analysed them by mass spectrometry (see Figure 7). This 
approach revealed a nice genotype-dependent clustering in the PCA (Figure 19A). 
Visualizing the dataset in a heat map again confirmed a separation of wild-type and 
vhl-1(ok161) samples (Figure 19B). 
 
Figure 19: PCA and heat map analysis of wild-type and vhl-1(ok161) proteome. 
A. PCA of wild-type (red dots) and vhl-1(ok161) (blue dots) proteome samples. B. Heat map analysis 
of wild-type and vhl-1(ok161) proteome samples. The iBAQ intensity scale goes from 16 (blue) over 23 
(white) to 30 (red). See also Esmaillie et al. 2019. 
 
5.3.2 Proteome analysis reveals activation of the hypoxia singling pathway in 
vhl-1(ok161) mutant worms 
After the quality check of the proteomes, we wanted to know if the protein levels of 
known HIF-1 targets are regulated in the vhl-1(ok161) worms as expected. Therefore, 
we marked all known HIF-1 targets (Dengler et al. 2014; Ortiz-Barahona et al. 2010; 
Shen et al. 2005) in the proteome including HIF-1 itself (Figure 20). Seven target 
genes and HIF-1 itself were significantly enriched in the vhl-1(ok161) mutant. 





Figure 20: Analysis of HIF-1 and its target genes in wild-type and vhl-1(ok161) proteome. 
Volcano plot shows log2 FC change of the wild-type proteome versus the vhl-1(ok161) proteome 
against the –log10 p-value of the wild-type proteome compared to the vhl-1(ok161) proteome. HIF-1 
target genes (Dengler et al. 2014; Ortiz-Barahona et al. 2010; Shen et al. 2005) are marked as black 
dots. Significant HIF-1 target genes are indicated with their names. HIF-1 is also marked with an 
arrow. See also Esmaillie et al. 2019. 
 
5.3.3 Annotation enrichment analysis of the proteome 
GO-term enrichment analysis of the proteome of wild-type and vhl-1(ok161) showed 
CoA desaturase activity, response to biotic stimulus and immune system process as 
the most enriched terms in biological processes and molecular function (Figure 21A). 
Analysis of the GO-terms of cellular compartment revealed two enriched terms, 
namely lysosome and vacuole (Figure 21B). For the domain analysis, we used Pfam. 






Figure 21: GO-term enrichment analysis of wild-type and vhl-1(ok161) proteome. 
For each bar diagram, the log2 enrichment factor is represented on the X-axis. The number next to 
each bar represents the number of proteins falling into each category followed by the category size. A. 
GO-term analysis of biological processes and molecular function. B. GO-term analysis of cellular 
compartments. C. Domain analysis using Pfam. See also Esmaillie et al. 2019. 
 
5.4 Analysis of the mode of regulation of RBPs in wild-type and vhl-1(ok161) 
5.4.1 The hypoxia signaling pathway regulates the abundance of RBPs 
We identified 1354 RBPs in the wild-type and vhl-1(ok161) RIC and wondered how 
the identified RBPs are regulated on the proteome level. To this end, we marked all 
the 1354 RBPs depicted in the volcano plot of the proteome (Figure 22A). Ten (ASP-
3, CTSA-2, C41G7.6, GLD-3, H28G03.1, MEX-1, OAT-1, PHY-2, R08E5.3, 
Y37A1B.5) of the RBPs were significantly upregulated whereas two (COL-8 and 





Figure 22: Identification of RBPs in the proteome of wild-type and vhl-1(ok161). 
A. Volcano plot depicting the proteomes from wild-type and vhl-1(ok161). The log2 fold change is 
plotted against the –log10 p-value. Black marked dots are RBPs whereas significant RBPs are marked 
also with their name. Grey dots are all other proteins identified in the proteome. See also Esmaillie et 
al. 2019. 
 
5.4.2 Analysis of RBPs identified exclusively in wild-type or vhl-1(ok161) RIC 
The RIC analysis identifies RBPs enriched in wild-type or vhl-1(ok161) mutant worms 
but does not allow for a conclusion whether this is due to altered RNA-binding 
intensity or differential regulation of the protein level of the respective RBP. To identify 
the mode of regulation of RBPs in the vhl-1(ok161) mutant we chose specific criteria 
to analyse the RBPome. Firstly, we analysed all RBPs which were measured three 
times in crosslinked samples of one genotype (e.g. wild-type or vhl-1(ok161)) but 
never in the other. This resulted in two lists of RBPs exclusively identified in either 
wild-type or vhl-1(ok161) mutant worms. The analysis revealed five RBPs only 
measured in vhl-1(ok161) crosslinked samples but not in wild-type crosslinked 
samples (Figure 23A). Analysis of these RBPs in the proteome shows that their 























Figure 23: RBPs measured exclusively 
in either wild-type or vhl-1(ok161) 
analysed in their proteomes. 
A. Table of RBPs measured exclusively in 
vhl-1(ok161) samples but never in wild-type 
samples. B. RBPs from table A are marked 
in black in the volcano plot of the 
proteomes from wild-type and vhl-1(ok161). 
The log2 fold change is plotted against the –
log10 p-value. C. Table of RBPs measured 
exclusively in wild-type samples but not in 
vhl-1(ok161) samples. D. RBPs from table 
C are marked in black in the volcano plot of 
the proteome of wild-type and vhl-1(ok161). 
The log2 fold change is plotted against the –





Interestingly, analysis of the RBPs exclusively measured in wild-type crosslinked 
samples but not measured in vhl-1(ok161) crosslinked samples identified twenty four 
RBPs (Figure 23C). All of these RBPs are also not differentially regulated in the 
proteome (Figure 23D), indicating that in the vhl-1(ok161) mutant the RBP binding 
capacity is changed but not the abundance. 
 
5.4.3 Identification of the mode of regulation of RBPs in wild-type and 
vhl-1(ok161) RIC 
Focussing on RBPs which were measured three times in crosslinked samples of one 
genotype is one way to analyse the data regarding modulation by hypoxia-signaling. 
Another way is to directly correlate the log2 fold changes of crosslinked versus non-
crosslinked samples in the RIC and compare both genotypes. We plotted 
vhl-1(ok161) log2 fold changes against wild-type log2 fold changes (Figure 24A). To 
identify RBPs which were enriched in wild-type or vhl-1(ok161) we calculated the 
95% prediction interval (grey lines, Figure 24A). All proteins above the interval and 
marked in red are RBPs enriched in the wild-type whereas all lines below the line 
marked in blue are enriched in vhl-1(ok161) (Figure 24A and Table 20). All proteins 
outside the 95% prediction interval (above or below the line) marked in grey are not 
in Class I or Class II. Analysing both the red and blue marked RBPs in the proteome 
revealed that all except for one protein - H28G03.1 - are not regulated on the protein 







Figure 24: Identification of mode of regulation of RBPs in wild-type and vhl-1(ok161). 
A. The scatterplot depicts the RIC of wild-type and vhl-1(ok161) mutant worms. The log2 FC of 
crosslinked versus non-crosslinked vhl-1(ok161) data against log2 FC of crosslinked versus non-
crosslinked wild-type data was plotted. The grey lines show the calculated 95% interval. Red marked 
dots represent RBPs enriched in wild-type whereas blue marked dots represent RBPs enriched in vhl-
1(ok161). Protein information of red and blue marked RBPs in Table 20 and http://shiny.cecad.uni-
koeln.de:3838/celegans_rbpome. B. Red marked RBPs from A. depicted in the wild-type and vhl-
1(ok161) proteome data. The log2 fold change is plotted against the –log10 p-value. C. Blue marked 
RBPs from A. depicted in the wild-type and vhl-1(ok161) proteome data. The log2 fold change is 















5.5 Hypoxia-signaling associated RBPs have an impact on C. elegans lifespan 
5.5.1 Establishing the lifespan machine in C. elegans 
The in-depth analysis of the wild-type and vhl-1(ok161) RIC revealed 80 RBPs which 
have differential RNA binding capacity in either wild-type or vhl-1(ok161) (Figures 23 
and 24). It is known that vhl-1(ok161) worms have an extended lifespan compared to 
the wild-type worms (Müller et al. 2009). We wondered if one or more of the RBPs 
identified in our analysis may be involved in lifespan extension. To answer this 
question, lifespan experiments in C. elegans are required. These experiments are 
laborious and time consuming, especially when run in a larger number of knockout 
strains or RNAi conditions. To enhance lifespan analysis, we decided to establish the 
lifespan machine developed by Nicholas Stroustrup in our group (Figure 25A, 
Stroustrup et al 2013). The lifespan machine is based on commercially available 
scanners, which are used to scan the plates containing worms in a specified time 
interval. This allows for the inclusion of much larger numbers of worms per condition 
compared to manual screens and a much more frequent scoring of mortality. 
Unfortunately, the scanners could not be used as purchased. Some of the scanners 
had to be converted and other components had to be built (see methods part 
4.2.1.7). On the other hand, there is no software that could be downloaded instantly 
to the PC. Many individual software packages had to be installed beforehand, 
connected to each other and run on a PC with the Linux operating system. On that 
computer the Worm Browser and the Image Server was than installed (Stroustrup et 
al. 2013). Image processing cuts the acquired images into plate pictures and 
identifies worms through contrast thresholding and morphology analysis. Movement 
analysis reconstructs each worm path and determines there time of death based on 
ceased movement. Afterwards the automatically generated survival data in the Worm 
Browser software is analysed and falsely identified objects are excluded manually. 
Also, the time point of death of each worm can be adjusted if incorrectly marked by 
the software. To visualize the resulting table into time-survival curves GraphPad 





Figure 25: Overview of the lifespan machine. 
A. The lifespan machine in the Nephrolab Cologne. Ten scanners are placed in a temperature-
controlled room. In the middle of the cupboard is a laptop running the acquisition server to monitor all 
the scanners. B. Agarose plates with worms inside are placed in the scanner by placing them upside 
down. The scanner is mounted with fans on their side. The airflow of the fans is indicated by the blue 
arrows.  After scans are completed images are overlaid and worms are identified by the software. The 
Worm Browser software allows confirming or refusing the identified worms. Completing the analysis 
the software transforms the data into a survival curve. Images modified from (Stroustrup et al. 2013). 
 
5.5.2 Lifespan analysis of long-lived mutants 
After setting up the lifespan machine we went on to test the performance of the 
device. All of the following lifespan assays were performed at 20°C in a temperature-
controlled room. We first checked the lifespan of wild-type worms (Figure 26A). The 
median lifespan of the wild-type worms showed  a similar range compared to 
previous manual results in our lab as well as data from other groups (D. H. Mitchell et 
al. 1979; Müller et al. 2009). We used 349 worms for the lifespan analysis and a scan 
interval of 30 minutes. To show that we were able to detect differential effects on 
lifespan we checked the lifespan of long-lived vhl-1(ok161) and daf-2(e1370) (Figure 




about 3 days (Müller et al. 2009). Inhibition of insulin signaling by daf-2 knockout is 
one of the best established settings of longevity with a lifespan more than twice as 
long as wild-type (Kenyon et al. 1993). As expected, in both experiments the mutant 
worms showed an increased lifespan comparable to published data. 
 
Figure 26: Automated lifespan analysis of C. elegans mutants. 
A. Lifespan analysis of wild-type worms. 349 worms were analysed and have a median lifespan of 20 
days. B. Lifespan analysis of wild-type (red, WT) and vhl-1(ok161) (yellow). 58 worms were analysed 
for wild-type and 84 worms for vhl-1(ok161). The median lifespan for wild-type is 16.5 days and for vhl-
1(ok161) 20 days. C. Lifespan analysis of wild-type (red) and daf-2(e1370) (blue). 70 worms were 
analysed for wild-type and 242 worms for daf-2(e1370). The median lifespan for wild-type is 21 days 




5.5.3 Lifespan analysis of worms fed on RNAi in the lifespan machine set-up 
The first analyses using the lifespan machine indicated that the machine was fully 
functional (Figure 26A-C). To analyse the effect of the RBPs on lifespan extension we 
designed an RNAi lifespan experiment. Commercially available RNAi libraries cover 
most of the coding genome of C. elegans including most the RBPs we wanted to 
analyse. However, before starting the analysis it appeared essential to show that the 
machine would provide reliable results for worms grown on HT115 E. coli that are 
used for the expression of dsRNA required for RNAi. We analysed wild-type worms 
fed bacteria expressing RNAi against daf-2 mRNA (Figure 27A).  
 
Figure 27: Lifespan analysis of C. elegans feed on RNAi. 
A. Lifespan analysis of wild-type worms feed with bacteria expressing empty vector (EV) RNAi (red) or 
daf-2 RNAi (blue). 88 worms were analysed for EV RNAi and 163 worms for daf-2 RNAi. The median 
lifespan for EV RNAi is 16.5 days and for daf-2 RNAi 27.5 days. B. Lifespan analysis of wild-type feed 
with bacteria expressing empty vector RNAi (red) or daf-16 RNAi (orange). 115 worms were analysed 
for EV RNAi and 36 worms for daf-16 RNAi. The median lifespan for EV RNAi is 18.5 days and for 
daf-16 RNAi 11 days (see also Table 12).  
We observed an increased lifespan, as showed before (Kenyon et al. 1993; Müller et 




FOXO transcription factor DAF-16 and knockdown of daf-16 in wild-type leads to a 
shortened lifespan (Kenyon et al. 1993). Therefore, we fed worms with bacteria 
expressing RNAi against daf-16 mRNA and were able to reproduce the known 
phenotypes (Figure 27B). These data confirm that the lifespan machine can analyse 
worms fed with bacteria expressing RNAi and be used to analyse the lifespan of the 
80 RBPs knockdowns. 
5.5.4 Knockdown of RBPs regulates C. elegans lifespan 
The RBPs we wanted to focus were derived from the in-depth analysis of the RIC 
and proteome of wild-type and vhl-1(ok161) mutant worms (Figures 23 and 24). In a 
first pilot screen, we examined 8 of them on the lifespan machine (Figure 28A).  
 
Figure 28: Lifespan analysis of RBP knockdown in C. elegans. 
A. Lifespan analysis of wild-type (WT) feed with bacteria expressing RNAi against: empty vector (EV), 
daf-2, atad-3, C46F11.4, R148.5, F42G8.10, M28.5 cdk-11.1, tat-5 and pfd-5. For each RNAi 
knockdown N > 50 worms. The median lifespan in days are for EV (17.14), daf-2 (28.10), atad-3 
(21.66), C46F11.4 (21.66), R148.5 (20.83), cdk-11.1 (20.16), tat-5 (16.79), pfd-5 (17.18), F42G8.10 
(23.35) and M28.5 (19.94). The experiment was performed once (see also Table 12). B. Overview of 
the RBPs tested in lifespan analysis. The numbers indicate detection of the RBPs in the crosslinked 
RIC samples of wild-type and vhl-1(ok161) mutant worms. atad-3, C46F11.4, R148.5, F42G8.10, 
M28.5 and pfd-5 were measured three times in wild-type crosslinked samples and never in 
vhl-1(ok161) crosslinked samples. cdk-11.1 and tat-5 were measured three times in vhl-1(ok161) 




The knockdown of 6 of these RBPs showed an increased lifespan compared to the 
wild-type. Interestingly, F42G8.10 RNAi showed an increase of six days median 
survival compared to the wild-type whereas the other five showed an increase of 2 to 
4 days. Analysis of the RIC revealed that five of the six lifespan increasing RBPs 
were identified exclusively in the wild-type crosslinked samples and one of them 
exclusively in the vhl-1(ok161) crosslinked samples (Figure 28B). 
5.5.5 CRISPR-Cas9 based Genome editing in C. elegans  
Using the lifespan machine we were able to identify RBPs potentially increasing the 
lifespan of wild-type worms upon downregulation. It is still unclear how these RBPs 
increase the lifespan. The identification of the RNA targets of these RBPs would be a 
first step towards testable hypotheses on how these RBPs potentially regulate the 
lifespan extension. The identification of RNA bound to RBPs is possible by cross-
linking and immunoprecipitation (CLIP) experiments (Ule et al. 2003). One of the 
crucial steps of CLIP is the isolation of a specific protein using immunoprecipitation 
protocols. In C. elegans, there are few validated antibodies against endogenous 
proteins available. To overcome this limitation we decided to use CRISPR-Cas9 
technology in the worm as reported before (Paix et al. 2017). We designed DNA 
oligos to fuse a 3xFLAG tag to endogenous RBPs N-terminally. We injected CRISPR-
Cas9 mix (dpy-10 ssODN and crRNA, pqn-53 ssODN and crRNA, Cas9, tracrRNA, 
KCl and HEPES pH 7.4) into the germline of the worm to tag pqn-53 (for details see 
Methods). pqn-53 contains a prion-like domain which is found in RNA binding 
proteins and it localizes to the nucleus (Hennig et al. 2015). In the analysed RIC it is 
defined as Class II RBP in both wild-type and vhl-1(ok161) mutant worms and is 
therefore a good candidate to establish CRISPR-Cas9. The insertion of dpy-10 
ssODN and crRNA into the CRISPR-Cas9 mix will cause a dumpy phenotype in the 
progeny of injected worms. Therefore successful injection was confirmed by the 
identification of the dumpy phenotype on the plates (Figure 29A). Worms showing a 
dumpy phenotype were isolated and a 3 primer based PCR showed their 
heterozygosity for an insertion when a second band at high 270 base pair appeared 
(Figure 29B). Heterozygous worms were singled and the progeny of these worms 
were screened for homozygosity by PCR. Worms supposed to be homozygous for 
insertion were confirmed by sequencing for successful insertion (Figure 29C). The 




blotting (Figure 29D). The time frame from injection to the new strain was three 
weeks. Therefore it is feasible to generate a considerably larger number of tagged 
RBP strains in the future. 
 
Figure 29: Genome editing using CRISPR-Cas9. 
A. Images of C. elegans after injection with CRISPR-Cas9 mix (dpy-10 ssODN and crRNA, pqn-53 
ssODN and crRNA, Cas9, tracrRNA, KCl and HEPES pH 7.4). Wild-type worms injected show dumpy 
phenotype in the F1 generation (right) compared to not injected worms (left). The scale depicts 200 
µm. B. PCR analysis of the F1 generation after injection. Worms with insertion show in additional of a 
band 200 bp band a 270 bp band (red boxes). C. Sequence analysis of worms with homozygous 
insertions is checked for the correct sequence of the FLAG insertion. The sequence on the top row 
shows the expected sequence upon FLAG insertion whereas the bottom row shows the sequencing 
result of pqn-53:3xFLAG line 1. D. Western blot analysis of three different strains generated by 






Preconditioning protocols have the potential to increase stress resistance in the 
kidney and thereby prevent AKI. One promising preconditioning protocol is the 
activation of the hypoxia signaling pathway. The key gene in the hypoxia signaling 
pathway is HIF. Although this pathway is well studied it has not been possible yet to 
transfer the findings to the clinical setting. Therefore, we aimed to gain a better 
understanding of the hypoxia signaling pathway. We focused on a group of important 
post-transcriptional regulator proteins, RBPs. The exceptional features of RBPs to 
bind RNA and to determine its fate make RBPs a key regulator in several pathways 
including the hypoxia signaling pathway (Masuda et al. 2009). How the hypoxia 
signaling pathway affects the RBP landscape is not yet understood. Therefore we set 
out to investigate the global impact of the hypoxia signaling pathway regarding 
RBPome. 
6.1 vhl-1(ok161) mutant phenotype and its impact in RIC 
When growing vhl-1(ok161) mutant worms we observed that they appear shorter 
compared to the wild-type worms. Microscopy revealed that they also have an 
increased width. Both characteristics are a typical phenotype in C. elegans reported 
as dumpy. This phenotype is caused by defects in the extracellular matrix (ECM) of 
the worms (McMahon et al. 2003). Interestingly, it was previously shown that human 
VHL can bind directly to collagen IV alpha 2 (G. Kurban et al. 2008). Additionally, 
inactivated VHL leads to remodeling of fibronectin and collagen IV resulting in highly 
vascularized tumors with increased invasive ability (G. Kurban et al. 2008; Ghada 
Kurban et al. 2006). It was also found that lifespan in C. elegans is partly linked to 
collagen which is the main component of ECM (Ewald et al. 2015). The upregulation 
of a single collagen gene can lead to an increased lifespan in the worm. Besides, it is 
known that vhl-1(ok161) mutant worms live longer compared to the wild-type worms 
(Mehta et al. 2009; Müller et al. 2009; Y. Zhang et al. 2009). Together these results 
suggest a direct link between the lifespan extension of vhl-1(ok161) mutant worms 
and potential changes in the ECM. The fact that the vhl-1(ok161) mutant worms show 
a dumpy phenotype comes with a couple of problems regarding the comparison to 
wild-type worms. In our RIC experiment, we used equal numbers of wild-type and 
vhl-1(ok161) mutant worms. RNA and protein analyses revealed that the RNA and 




worms even when the same worm number was extracted. An explanation for this 
reduction of RNA and protein content could be the smaller body size of vhl-1(ok161) 
mutant worms. Besides, changes in the worm cuticle (as indicated by the dumpy 
phenotype) could lead to differences in the efficiency of RNA and protein extraction. 
To compensate for this imbalance regarding the whole proteome we normalized the 
data to protein amount after measurement of wild-type and vhl-1(ok161) mutant. 
However, normalization would not have easily been possible for the corresponding 
RIC experiment. To overcome this challenge in the RIC experiment, we saturated the 
beads with RNA indicated by the measured RNA yield after pulldown which should 
make the results independent from the differences between the two strains. 
Nonetheless we cannot exclude a resulting bias introduced into the comparison 
between wild-type worms and vhl-1(ok161) mutant worms completely. More 
confirmatory experiments regarding single RBPs differentially regulated by hypoxia 
signaling will be required to address this aspect conclusively. Here, 
immunoprecipitation of specific proteins in combination with polynucleotide kinase 
assays or RNAseq (in the sense of crosslinking and immunoprecipitation) will be 
helpful in the future. These experiments will be enabled by the CRISPR-based 
introduction of Flag-tags as established in my project. 
6.2 The complexity of RIC protocols 
We performed RIC by using wild-type and vhl-1(ok161) mutant worms and identified 
in total 2473 proteins for wild-type and vhl-1(ok161) mutant worms. We chose 
intensity-based absolute quantification (iBAQ) as our analysis strategy due to the 
expected large difference regarding the number of proteins measured between 
crosslinked and non-crosslinked samples. For the proteome, we wanted to keep the 
comparability to the RBPome as high as possible and consequently used iBAQs as 
well. Performing PCA and hierarchical clustering we came to the conclusion to 
exclude one non-crosslinked sample for each wild-type and vhl-1(ok161) mutant 
worms as the number of proteins measured was unexpectedly high for these 
samples. Additionally, the corresponding crosslinked samples revealed fewer 
proteins measured than in the non-crosslinked outliers. This is most likely explained 
by contamination with whole worm lysates underlining that these samples needed to 
be excluded as outliers. We are aware that three biological replicates are favourable 




identification of a high number of significantly enriched RBPs showing that two non-
crosslinked controls were sufficient for our purpose. Furthermore, earlier RIC 
experiments have shown that reliable datasets can be built on two biological 
replicates (Baltz et al. 2012; Castello et al. 2012; Liepelt et al. 2016; S. F. Mitchell et 
al. 2013). Castello et al. used two UVC crosslinked and non-crosslinked samples and 
compared these to one UVA crosslinked and non-crosslinked sample pre-treated with 
4SU revealing comparable results (Castello et al. 2012). Liepelt et al. pooled their 
non-crosslinked replicates from different conditions (+/- LPS) for all downstream 
analyses considering the stable results in non-crosslinked samples between 
conditions (Liepelt et al. 2016). As expected in the non-crosslinked samples, most 
proteins are washed off due to lack of covalent bonds. In our dataset, 502 proteins 
were exclusively detected only in crosslinked samples making it impossible to 
perform any statistics with these proteins as they are not measured in the non-
crosslinked samples. Obviously, these proteins are very likely to be indeed RBPs and 
were defined as such in our analyses. Taken together, we detected 1354 RBPs for 
wild-type and vhl-1(ok161) mutant worms in the RIC. Our analysis indicates that at 
least 6.8% of protein coding genes in C. elegans encode RBPs. That number 
exceeds the predicted 4.4% (Tamburino et al. 2013) showing the restrictions of 
computational RBP prediction algorithms. 
6.3 Interspecies data comparison 
To get a deeper understanding of both the quality and the content of our dataset we 
compared it to published RIC datasets. To date, the only other RBPome performed in 
C. elegans was published by Matia-González et al. (Matia-González et al. 2015). The 
overlap between our dataset and that from Matia-González et al. is approximately 26 
percent. The limited overlap with the previous study characterizing the worm 
RBPome is most likely due to differences in the experimental setup regarding mass 
spectrometry and more importantly, the choice of controls. Matia-Gonzalez et al. 
used RNase ONE treated and poly(A) competitor controls, whilst we employed non-
crosslinked controls. Additionally, we used exclusively young adult worms whereas 
they used either a mixed worm stage population or L4 stage worms. Also, we 
identified 1354 RBPs whereas they identify 594 RBPs. To further extend the analysis 
we compared our dataset with datasets that include human, worms, mouse and were 




elegans, we converted gene identifiers into their orthologues from human, mouse, fly 
and yeast. This came with the additional challenge that the conservation of gene sets 
differs between these organisms. Consequently, many cases of RBPs identified in 
one of the datasets but not found in ours may be the result of a lack of (known) 
conservation. To complete the comparisons we also used data coming from novel 
approaches that identify RBPs from total RNA (Queiroz et al. 2019; Trendel et al. 
2019; Urdaneta and Beckmann 2019). The number of identified RBPs in these novel 
approaches was higher possibly due to the fact that these protocols do not enrich for 
polyA-tailed RNA binding but reveal RBPs bound to all different types of RNA. More 
than 65 percent of our identified RBPs were covered by these datasets. Although the 
overlap of our data with the C. elegans dataset by Matia-González et al. is 26 
percent, the comparison to RBPomes from other species revealed that 80 percent of 
our RBPome were already known as RBPs (Hentze et al. 2018; Ignarski et al. 2019; 
Queiroz et al. 2019; Trendel et al. 2019; Urdaneta et al. 2019). In addition, the fact 
that many classical RBDs were identified in our dataset by domain enrichment 
analysis shows that we actually identified RBPs. Taking this into consideration and 
the fact that we have an increased detection of RBPs compared to Matia-Gonzalez 
shows our RIC was more sensitive possibly due to differences in the protocol and 
due to technological progress in the field of mass spectrometry. In addition to the 
increasing choice and improvement of technologies, the characterization of RBPs in 
specific biological settings such as hypoxia will also increase the number of proteins 
identified. Proteins that are only expressed under these specific conditions can only 
be identified as RBPs under these circumstances. For instance, performing a RIC 
using mIMCD-3 cells maintained under either normoxic conditions or six hours under 
hypoxic conditions resulted in six RBPs that were identified exclusively in hypoxic 
conditions (Ignarski et al. 2019). Moreover, two RBPs were exclusively identified 
upon induction of germline apoptosis in C. elegans (Matia-González et al. 2015). 
However, only a few studies have used specific biological conditions to carry out RIC 
to date. In our dataset, we noticed that the novel RBPs identified either exclusively in 
wild-type or vhl-1(ok161) mutants are overrepresented by 38 percent compared to 
the entire dataset by 20 percent. That finding speaks again for RIC experiments in 
certain biological conditions to identify all RBPs. Since efficient crosslinking is a 
crucial step in RIC, not all type of samples are appropriate for this technique. As soon 




result, primarily cell monolayers have been used for these experiments limiting our 
understanding of biological processes in RBP regulation to this rather artificial setting. 
Since, C. elegans is transparent and has a diameter of 50 µm (Maguire et al. 2011), 
crosslinking does indeed reach sufficient efficiency and RIC can be performed. This 
enables an insight into the RBPome in a living model organism. As an alternative to 
UVC crosslinking performed in our study, irradiation with UVA in combination with a 
photoreactive ribonucleoside analog such as 4SU can be used (Baltz et al. 2012; 
Beckmann 2017; Castello et al. 2012; Ignarski et al. 2019). 4SU is incorporated into 
newly transcribed RNA and can also be used for instance to analyses the half-life 
and degradation of an RNA (Tani and Akimitsu 2012). It allows to globally identify the 
RNA segments that are crosslinked by the mRNA-bound proteome (Baltz et al. 
2012). Unfortunately, it has been shown that C. elegans absorbs little of the 4SU 
compared to HEK239 cells (Jungkamp et al. 2011). In addition, 4SU itself shows 
certain toxicity and therefore may have an impact on the results (Lozzio and Wigler 
1971). The efficient crosslinking of organs is just as challenging. So far RIC was not 
performed on whole organs. However, in CLIP experiments and in the novel 
approach that identify RBPs (PTex) mouse-brain tissue was used (Licatalosi et al. 
2008; Ule et al. 2003; Urdaneta et al. 2019). Before irradiation the mouse-brain was 
disrupted by cryogenic grinding resulting in efficient crosslinking (Urdaneta et al. 
2019). Another recent study improved RIC UV-crosslinking efficiency in leaves with a 
possibility to adapt that approach to animal organs (Bach-Pages et al. 2020). The 
constant improvement of the RIC method will make it possible to use all types of 
samples in the future and thus to identify new RBPs. 
6.4 The impact of hypoxia signaling on the RBP landscape 
The main goal of my thesis was to understand how the hypoxia signaling pathway 
influences the RBP landscape. To that end, we compared the RIC data of wild-type 
worms to vhl-1(ok161) mutant worms. The stabilization of HIF-1 in vhl-1(ok161) 
mutant worms leads to the activation of various target genes. We hypothesized that 
RBPs exist among these targets genes. The analysis of the proteome of wild-type 
and vhl-1(ok161) mutant worms showed that 12 out of 1354 of the identified RBPs 
are differentially regulated upon HIF-1 stabilization. Interestingly, among these 
proteins PHY-2 was upregulated and COL-8 was downregulated in vhl-1(ok161) 




extracellular matrix (Cox et al. 1989; Friedman et al. 2000). The finding may link 
RBPs to the ECM phenotype observed in vhl-1(ok161) mutant worms. How ECM 
formation and ECM components may be functionally linked to RBPs is not clear at 
the moment and will require future studies. The majority of RBPs do not seem to be 
regulated at the protein level but rather at the level of RNA binding. A group of RBPs 
that appeared especially interesting to us were those proteins which were exclusively 
detected in RIC from either wild-type or vhl-1(ok161) crosslinked samples. We 
identified exclusively in vhl-1(ok161) crosslinked samples tag-65, tat-5, ensa-1, cdk-
11.1 and orc-3. Both tat-5 and orc-3 are novel RBPs without classical RBD and 
therefore belong to the enigmRBPs. tat-5 human ortholog is ATPase phospholipid 
transporting 9A (ATP9A). In C. elegans tat-5 was shown to be involved in the 
regulation of extracellular vesicles release and this finding has been confirmed in 
mammals (Naik et al. 2019; Wehman et al. 2011). The human ortholog of tag-65 is 
the calcium homeostasis endoplasmic reticulum protein (CHERP). It modulates 
intracellular Ca2+ homoeostasis and was observed as splicing regulator as a U2-
related protein (Laplante et al. 2000; Wang et al. 2019). The human orthologue ensa-
1 is cAMP regulated phosphoprotein 19 (ARPP19) and endosulfine alpha (ENSA). 
Together they are important for the control of mitosis and its M- and S-phases (Castro 
and Lorca 2018). The human orthologue of Cdk-11.1 is CDK11A and similar to ensa-
1 human orthologs it is involved in cell cycle regulation (Liu et al. 2017). orc-3 is not 
conserved in humans but there is evidence that it is involved in C. elegans germ-line 
development (Hanazawa et al. 2001). The fact that nothing of their protein function 
indicates RNA binding capacity is typical for enigmRBPs (Beckmann et al. 2015). A 
special group of these enigmRBPs are the metabolic enzymes. One well-
characterized example is the iron regulatory protein 1 (IRP1) (Anderson et al. 2012). 
IRP1 binds to iron-responsive elements (IREs) in the 5′ or 3′ untranslated regions of 
mRNAs and can block mRNA translation (5′ UTR binding) or leads to mRNA 
stabilization (3′ UTR binding). Thus IRP1 controls mRNAs encoding proteins involved 
in iron homeostasis and thereby maintain intracellular iron levels (Anderson et al. 
2012; Hentze et al. 2010). However, RNA may also affect enzymes by changing their 
activity, complex formation or stability. Other possibilities of RNA/enzyme interactions 
have been proposed, it is imaginable that RNA binding blocks the catalysis 
performed by an enzyme or that RNA binding is needed to bridge between complex 




regulate enzymes still need to be tested. Even though the 5 proteins were exclusively 
identified in vhl-1(ok161) samples there is no link to hypoxia signaling found in the 
literature. This could be due to the fact that these proteins were also not regulated in 
the proteome so that they do not stand out in a “normal” analysis. Consequently, RIC 
adds another layer of complexity to our understanding of this pathway and an insight 
into how RNA-binding of these proteins changes upon hypoxia as well as the 
consequences of RNA-binding to cellular biology would be extremely interesting. A 
study by our laboratory that performed a RIC in hypoxia-treated mIMCD-3 cells has 
also shown that the RNA binding of RBPs changes rather than the occurrence of the 
RBPs (Ignarski et al. 2019). In total 12 proteins were identified in their RIC that 
reaches significant exclusively in one condition and therefore assigned as RBP. Six of 
them in mIMCD-3 cells treated with normoxia and six of them in mIMCD-3 cells 
treated with hypoxia. The comparison to my data showed that two of these twelve 
RBPs have a similar pattern. The protein SDAD1 in mouse is labeled as RBP 
exclusively in hypoxic mIMCD-3 cells and its C. elegans ortholog pro-3 is only found 
in the vhl-1(ok161) mutant worms. SDAD1 has been shown to promote proliferation 
of colon cancer cells by reducing apoptosis (Zeng et al. 2017). On the other hand, 
TCP1 in the mouse was labeled as RBP only in normoxic mIMCD-3 cells and its C. 
elegans ortholog cct-1 was found in RIC only in wild-type worms. TCP1 is a type II 
chaperonin that sequestered and folded newly synthesized or misfolded proteins in a 
ATP dependent manner (Showalter et al. 2020). Interestingly, one study shows that 
TCP1 can be associated with the recovery from AKI (Blanco-Gozalo et al. 2020) and 
could be a viable target for therapeutic development. 
6.5 The C. elegans lifespan machine 
Since the link between hypoxia-regulated RBPs and stress resistance mediated by 
hypoxic preconditioning is at the heart of our research interest moving on to a 
phenotype analysis based on our RIC data was the logical next step. In C. elegans 
stress resistance is coupled with lifespan extension. Often, increased stress 
resistance is directly proportional to an increased lifespan in worms for the majority of 
pathways studied to date (Zhou et al. 2011). We wanted to study if the regulation of 
one of the identified RBPs in the vhl-1(ok161) mutant worms is also involved in 
increased lifespan. To this end, we first initiated establishment of the lifespan 




laboratory. 14 plates (6 mm) with 50 worms each fit on each scanner. This enables us 
to carry out lifespan analyses with 7000 worms at the same time. When setting up 
the machine we first solved obvious problems such as the heat generated by each 
scan by equipping them with fans. We also sealed the plates so that they did not dry 
out and reduced bacterial contamination. We tested the lifespan machine by using 
wild-type, vhl-1(ok161) and daf-2 mutants. Noticeably, the lifespan curves of the wild-
type differ between experiments. That can be explained by the different number of 
worms used in each experiment. We noticed that the number of worms influences the 
pattern of the curve. When using more worms we had more data points for each time 
point making the curve more continuous. Unfortunately, a high number of worms are 
not always guaranteed due to the number of strains used and exclusion of plates due 
to contamination. Considering the great opportunity and simplification of lifespan 
experiments linked to the lifespan machine the capacity of the machine was fully 
utilized soon after its establishment. Consequently another 15 scanners are currently 
being planned to extend the lifespan machine. That would allow us to analyse the 
lifespans of 17500 worms at the same time. The lifespan machine can be handled by 
a single scientist. Consequently, the number of experiments possible for one scientist 
is greatly enhanced by this device enabling fast lifespan screening. Although the 
lifespan machine offers many advantages over manual counting, unfortunately 
FUdRs need to be supplemented into the NGM agar. FUdR sterilizes the worm that 
no offspring can arise that is eaten up the food. Unfortunately, FUdR treatment itself 
can affect the lifespan of mutant worms but not the lifespan of wild-type worms 
(Aitlhadj and Stürzenbaum 2010; Park et al. 2017). An alternative to FUdR would be 
to use RNAi to prevent progeny. A possibility would be an RNAi construct targeting 
mex-3 that has already been used successfully in Stroustrup lab. MEX-3 is important 
for the anterior–posterior asymmetry in embryos and therefore upon downregulation 
leads to embryonic lethality (Draper et al. 1996). Further, the data generated by the 
lifespan machine can potentially be used beyond the mere analysis of nematode 
lifespan. This phenotype is evaluated by registration of movement and the worm 
position on the plate. This data could also be used to analyse the movement patterns 
of the worms including a number of additional phenotypic assays such as chemotaxis 





6.6 RBPs involved in C. elegans lifespan 
We then went on to perform the first pilot lifespan screen of RBPs identified in my 
project. Knockdown of atad-3, C46F11.4, R148.5, cdk-11.1, F42G8.10 and M28.5 
increased the lifespan of wild-type worms. As described before cdk-11.1 human 
ortholog is CDK11A and was exclusively detected in vhl-1(ok161) mutant worms. 
Knockdown of cdk-11.1 is linked to slow growth (Pothof et al. 2003). We observed the 
same in vhl-1(ok161) mutants and slow growth is frequently observed in long-lived 
strains (Y. Lee et al. 2016). C46F11.4 human ortholog is the DEAD box protein 
Ddx42. Ddx42 and is known to interact with the apoptosis inducer ASPP2 (Uhlmann-
Schiffler et al. 2009). For C46F11.4 an RNAi screen indicates extension of the 
lifespan of a short lived mutant (Xie and Roy 2012). atad-3 is involved in 
mitochondrial iron and heme homeostasis (van den Ecker et al. 2015). It has been 
shown that atad-3 RNAi promotes longevity in C. elegans confirming our results 
(Hoffmann et al. 2012). The human ortholog of atad-3, ATAD3A has been found to be 
overexpressed in various types of cancer (Teng et al. 2019) which could point 
towards a potential role as a factor ensuring growth and survival. The human ortholog 
of M28.5 is SNU13. SNU13 is one of the four core proteins of C/D small nucleolar 
RNPs (snoRNPs) that are involved in post-transcriptional modifications (Quinternet et 
al. 2016). Interestingly, the human orthologues of F42G8.10, NDUFB11 are 
implicated in microphthalmia (van Rahden et al. 2015). The deletion of VHL in retinal 
pigment epithelium was also linked to microphthalmia (Lange et al. 2012). Taken 
together, our screen identifies highly interesting RBP candidates that may be involved 
in increased stress resistance and longevity upon activation of hypoxia signaling. 
Epistasis experiments with vhl-1/hif-1 will now be needed to further corroborate this 
link. Before studying the RBPs identified in our screen, a validation of their actual 
RNA binding capacity should be carried out. A well-established method is 
immunoprecipitation and radioactive labeling of co-purified RNA (PNK assay) (Tawk 
et al. 2017). This has already been successfully carried out on HEK293T cells in our 
laboratory (Ignarski et al. 2019). In C. elegans we were able to perform successfully 
an immunoprecipitation of an FLAG tagged RBP and are now working to carry out 
the PNK assay. As soon as RBPs are confirmed of their RNA binding capacity, it 
would be of great importance to identify the RNA targets using CLIP protocols 




6.7 Future perspectives to elucidate RBPs in AKI 
Our results show that RBPs are regulated by the hypoxia signaling pathway and that 
their RNA binding capacity is affected by this pathway. This is particularly interesting 
since one of these RBPs could also have the potential – like hypoxia itself - to 
prevent AKI. That modulation of these RBPs has already a beneficial effect in the 
organisms as we could show by an increased lifespan of the worms. So far it remains 
open whether this increased lifespan is also dependent on the activation of the 
hypoxia signaling pathway. Nonetheless, modulation of these specific RBPs could be 
a targeted way to activate stress resistance in the future. To move closer to this goal, 
knowledge on the actual transcripts bound by these RBPs would be crucial. As 
discussed before CLIP experiments could answer this question (Ule et al. 2003). 
Once the RNA targets are known binding to these targets can be modulated using 
antisense oligos targeting the binding sites (Van Nostrand et al. 2016). On the one 
hand, this approach would allow to elucidate which binding events are indeed 
involved in the increase of stress resistance. On the other hand, antisense therapies 
have become a new option in clinical care and considering the rapidly increasing 
number of such therapies that have been approved in the last years, this can get a 
first step towards clinical translation. However, transferring these results to mammals 
is obviously a key step that has to be performed beforehand. Here, experiments in 
cell culture using human and mouse cells can be used to show that the RBP is 
influenced by hypoxia on the one hand and that the binding of the RBP to the target 
RNA is conserved on the other. If these results are satisfactory, the hypotheses need 
to be tested in murine AKI models (e.g. ischemia-reperfusion or cisplatin toxicity 
(Hesketh et al. 2014; Späth et al. 2019; Xu et al. 2015)) modulating the RBP of 
choice either using antisense oligos or genetic interventions (e.g. mutation of the 
RNA-binding domain). Obviously, the way towards clinical translation will be a long 
one. Nonetheless, the molecular understanding gained in models like the ones used 
in this project is the crucial step to start such endeavors and creating entirely new 
opportunities. Such novel strategies are urgently awaited since – despite research on 
AKI for many decades – classical approaches have not yielded any targeted 






Preconditioning protocols have the potential to prevent AKI. Unfortunately, these 
protocols cannot be used in the clinic yet because too little is known about their 
molecular mechanisms. One of the underlying mechanisms of these preconditioning 
protocols is the activation of the hypoxia signaling pathway. HIF activation as the 
center of the hypoxia signaling pathways has a profound impact on cellular biology. 
However, it is not known which factors play the most important role regarding stress 
resistance. In the scope of this thesis we were able to generate proteome and 
RBPome datasets of wild-type and vhl-1(ok161) mutant worms using RIC. Our data 
suggest that the hypoxia signaling pathway modulates the RBPome landscape. In 
particular, it seems that the RNA binding capacity rather than the protein abundance 
of the RBPs is changed. Similar observation has already taken place in cell culture as 
well. C. elegans can now be used to examine the hypoxia-inducible factor signaling 
and its modulation of the RBPs further by using RNA interference and mutant strains 
highlighting the worm as a good model organism. In total, we identified 80 RBPs that 
were modulated by the hypoxia signaling pathway. The lifespan machine established 
in scope of this work will make it possible to examine the lifespan of worms upon 
knockdown of all of these RBPs in the near future. However, of the eight RBPs that 
we have analysed so far, six have already shown that they actually play a role in 
extending the lifespan. In summary, we can say that our results have not only 
expanded the repertoire of RBPs in general, but also filled the gap of which RBPs are 
modulated by the hypoxia signaling pathway. This enables to select candidates that 
can be examined further, which in turn means a major step towards our 
understanding of the modulation of the hypoxia signaling pathway for future 
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